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A cross section of unopened aorta from 19 months old 
rabbit shows circumferential advanced lesion (x 25, elastic 
van Gieson). 
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The present thesis discusses the rabbit models in atherosclerosis 
research. The thesis is based on literature studies and on own experience and 
data obtained through the experimental work with the three rabbit models: 
homozygous Watanabe heritable hyperlipidemic @VHHL) rabbit, 
heterozygous WHHL rabbit fed 1% cholesterol, and cholesterol-fed rabbit 
based on a normolipidemic strain, the results of which are included in part 
III, chapters A - F. 
The chapters III.A.l, 1II.B. III. C., BID. and IILF. contain the results 
already published elsewhere. Chapter III.A.2. contains yet unpublished 
results. Chapter II1.E. contains an unpublished paper but the abstract based 
upon this study has already been published. 
In the published papers, the following work was performed by the author 
of this thesis and independently of the co-workers of the publications: 
Paper in chapter lII.A.l.: study design, development and maintenance of 
breeding colony of WHHL rabbits, characterisation of breeding performance 
of WHHL rabbits, statistical analysis and interpretation of data on 
physiological blood lipid levels in growing homozygous and heterozygous 
WHHL rabbits and the comparison of the blood lipid levels in growing 
WHHL rabbits to those in growing normolipidemic rabbits, and preparation 
of the manuscript; 
Paper in chapter IKB.: design of the time course for breeding of the 
WHHL rabbits and the distinction between the heterozygous and 
homozygous offsprings, supervision of the clinical course of the study, post 
mortem examination, sampling of tissue for microscopic examination; 
Papers in chapters IILC. and IILD.: study design, supervision of clinical 
course of the study, post mortem examination, sampling of tissue for 
microscopic examination, statistical analysis and interpretation of data on 
body weight, feed intake, blood lipids, cholesterol content in aorta (IILC.) 
and atherosclerotic lesions (IILC), preparation of the manuscripts; 
Paper in chapter lII.F.: design of the time course for breeding of the 
WHHL rabbits and the distinction between the heterozygous and 
homozygous offsprings, supervision of the clinical course of the study, post 
mortem examination, sampling of tissue for microscopic examination, 
statistical analysis and interpretation of data on body weight, feed intake and 
blood lipids. 
The study reported in chapter III.A.2. was carried out and the manuscript 
was prepared strictly by the author of this thesis. 
In the study reported in chapter IILE. the following work was performed 
strictly by the author of this thesis and independently of the co-workers: 
design of the time course for breeding of the WHHL rabbits and the 
distinction between the heterozygous and homozygous offsprings, study 
design, supervision of the clinical course of the study, post mortem 
examination, sampling of tissue for microscopic examination, statistical 
analysis and interpretation of data on body weight, feed intake, blood lipids, 
cholesterol content in the aorta, atherosclerotic lesions, and preparation of 
the manuscript. 
Furthermore, the author of this thesis gained practical experience with 
methods for measurement of blood lipids during the studies from chapters 
III.A.l. & 2. and IILC., and with preparation of the tissue for microscopic 
examination including fixation, embedding in paraffin, sectioning and 
staining, and the methods for macroscopic and microscopic qualitative and 
quantitative evaluation of atherosclerosis under the guidance of dr. med. 
Birgit Fischer Hansen on the material from the study in chapter IKB. 
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PART I 
INTRODUCTION 
LA. AIM OF THE PROJECT 
The present project has been made in the Institute of Toxicology in 
the National Food Agency. The aim of the project was 1) to establish three 
rabbit models for human atherosclerosis, 2) to use the rabbit models for 
investigation of possible effects of dietary fats and drug intervention on 
atherosclerosis, and 3) to evaluate the rabbit models. For this purpose 
followinpr has been oerformeck 
establishment of a breeding colony of Watanabe heritable hyperli- 
pidemic QVHHL) rabbit and comparison of reproductive perfor- 
mance of WHHL and New Zealand White (N’ZW) females (chap- 
ter ILB., III.A.l.), 
description and comparison of the physiological blood lipid levels 
in growing (chapter III.A.l.) and adult (chapter III.A.2.) normo- 
lipidemic and spontaneously hyperlipidemic rabbits, 
evaluation of the morphology of spontaneous atherosclerosis in 
heterozygous and homozygous WHHL rabbits (chapter BIB.), 
comparison of the atherogenic effect of margarine (hydrogenated 
fat) and olive oil in the cholesterol-fed rabbit based on a normoli- 
pidemic strain and description of morphology of atherosclerotic 
lesions in this model (chapter IILC.), 
description of the morphology of experimental atherosclerosis in 
the heterozygous WHHL rabbit fed diet with 1% cholesterol and 
evaluation of the usefulness of this model to investigate the at- 
herogenic effect of dietary fats using fats containing vegetable n-6 
and marine n-3 polyunsaturated fatty acids (chapter III.D.), 
comparison of the effect of fish and olive oils on the development 
of spontaneous atherosclerosis in homozygous WHHL rabbits 
(chapter IILE.), 
investigation of the effect of the calcium antagonist (-)-anipamil 
on spontaneous atherosclerosis in homozygous WHHL rabbits 
(chapter ELF.), 
discussion of the position, usefulness and application of 3 rabbit 
models: cholesterol-fed rabbit based on a normolipidemic strain, 
homozygous WHHL rabbit and heterozygous WHHL rabbit in 
atherosclerosis research, and comparison of cholesterol-fed and 
homozygous WHHL rabbit models (chapter IV. A.l-3.). 
I.B. ATHEROSCLEROSIS IN MAN 
Atherosclerosis and its clinical sequela coronary heart disease (CHD) is 
a major cause of premature death in the modem world accounting for 40% 
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of death in middleaged men. In Denmark, people with cardiovascular 
disease comprise one of the largest patient groups, about 225000 people. 
Every year 25000 Danes die from CHD or expressed in another way one 
Dane dies from CHD every twenty minutes (Hjertenyt august 1991). CH0 
kills more than 180000 people in the UK and 500000 in the USA (Durr- 
ington, 1993). Besides CHD, atherosclerosis also contributes to cerebral 
infarction, gangrene and loss of function of the extremities. Therefore great 
efforts are being done to understand the pathogenesis of atherosclerosis in 
order to prevent and cure the disease. 
I.B.l. Pathogenesis of atherosclerosis 
Atherosclerosis is a complex disease of the arterial intima and media 
due to interaction between plasma lipoproteins (Fig. 1, p. 11) and cells of 
the arterial wall. It is influenced by genetical and environmental factors of 
which the diet is assumed to be an important one. The effect of the diet on 
the development of atherosclerosis is, in part, mediated through the influen- 
ce of dietary fats on plasma levels of low density lipoprotein (LDL) choles- 
terol and by possible thrombogenic or antithrombogenic properties of fatty 
acids @‘y&-c% et al. 1994). Furthermore, other dietary components e.g. die- 
taty fibres, complex carbohydrates and polyphenolic antioxidants in veg- 
etable foods may play a role as protective factors (Hennig et al. 1994, 
Hertog 1994). 
Several reviews concerning the pathogenesis of atherosclerosis are 
available (Ross 1993, Getz 1990, Munro et Cotran 1988). The presently 
most widely accepted hypothesis for the pathogenesis is that atherosclerosis 
is a response to an injury. Different factors may cause injury e.g. hyper- 
cholesterolemia, hypertension, diabetes, obesity, chemical toxin as cigarette 
smoke, bacterial toxins, different mechanical factors, immunological fac- 
tors, viruses, homocysteine, oxidized LDL, oxidative stress, fatty acid 
composition of the diet. According to this hypothesis (Ross 1993, Th.oq- 
son 1994) the injury factors alter the function of endothehal cells of intima 
of arterial wall and promote increased adherence of monocytes, 
macrophages and T lymphocytes to vessel endothelium. Subsequently, 
these cells migrate between the endothelial cells into the arterial wall and 
localize subendotbelially and form cell aggregations. The macrophages 
accumulate fat and become large foam cells. These lipid rich macrophages 
together with T lymphocytes form fatty sneaks - the earliest recognizable 
light microscopic lesion within the intima Fatty streaks progress to inter- 
mediate fibrofatty lesions composed of layers of macrophages and smooth 
muscle cells and ultimativelly develop into fibrous plaques. Fibrous plaques 
increase in size as they accumulate more cells and the macrophages sca- 
venge more lipids and become foam cells. These processes lead to transfor- 
mation of the fibrous plaques to advanced lesions which are covered by 
dense caps of connective tissue with embedded smooth muscle cells that 
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Fig. 1. From: Mortem A: Transgenlc laboratory animal 
atherosclerosis research. &and J Lab Anlm Sci 1995, 22: 133-143 
models in 
A schematic presentation of the lipoprotein metab&sm. In the intestine the dietary 
cholesterol together with triglycerides is built into chylomlcrons which are then transported 
by lymph into the bloodsaeam. In the capillary vessels tbe chylomicmns are hydrolyzed to 
chylomicron remnants by lipopmtein lipase (LPL) and hepatic lipase @IL). Chylomicron 
remnants are taken up by remnant receptors (RR) in the liver. Cholesterol from the 
chylomicmn remnants is 1) secreted in the bile (as choksteml or biIe salts) into the 
intestines and 2) is used in tbe synthesis of very low density lipoproteins (VLDL), which 
are secreted into the blood. In the circulation VLDLs are hydrolized to intermediate 
density lipoproteins (IDL) by LPL and I-IL. IDLs 1) bind to the low density lipoprotein 
receptor (LDLR) and are transported into the liver cells, and 2) are catakolized to low 
density lipoprotein (LDL) in the blood stream. LDLs are 1) taken up by LDLR in liver 
cells and peripheral cells, and 2) some of them undergo modification in the circulation and 
then bind to the scavenger eceptor (SR) and are @ansported into scavenger cells. High 
density lipoproteins (HDL) are directly produced both in the liver and intestine. HDL 
constimens are also derived from chylomicron and VLDL catabolism. There are two main 
types of HDLs: HDb and HDb. HDLs serve as acceptors of lipids especially free 
cholesterol from varying tissues. Freqcholesterol is then estritied due to reaction mediated 
by lecitin cholesteryl acyltransferase (LCAT). Cholesterol esters are then hansferred from 
HDLs to other lipoproteins nonspecifically, as well as’by cholesteryl ester transfer protein 
(CETP). HDLs contribute in the transport of cholesterol from periphery to the liver. 
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usually overlays a core of lipid and necrotic debris. Some of lipid laden 
macrophages in advanced lesions may migrate back to the lumen of the 
vessel pushing apart the endothelial cells. Sites where endothelial disjunc- 
tion occurs become thrombogenic and platelet mural thrombi may form 
there. Platelet mural thrombi, activated macrophages and possibly also 
smooth muscle cells of the atherosclerotic lesion release many growth 
factors which induce the progression of advanced lesions. The ruptures or 
fissures in the advanced lesions lead to haemorrhage into the plaque, 
thrombosis and occlusion of the artery with the clinical consequence in the 
worst case being a sudden death from myocardial infarct. 
I.B.2. Familial hypercholesterolemia in man 
Atherosclerosis develops very slowly over the years. The clinical 
manifestation of the disease usually occurs in middleaged humans. Howe- 
ver, people with genetic defects in the lipid metabolism may develop the 
disease earlier. One of the genetic syndromes leading to premature athe- 
rosclerosis is familial hypercholesterolemia (FH). FH is a dominant, inher- 
ited condition which affects approximately 0.2% of the population. It is a 
result of a defect in the LDL receptor due to mutation of its gene on 
chromosome 19. Since the LDL receptor plays a major role in the catabo- 
lism of LDL (see Fig. 1, p. 1 I), an LDL receptor deficiency or errors in its 
function result in accumulation of LDL in the plasma. There are five dif- 
ferent classes of mutations of the LDL receptor which give rise to FH. 
Each mutation includes several distinct gene defects. In the class 1 muta- 
tion the immunologically detectable LDL receptors are absent. Iu class 2 
the transport to the cell surface of any LDL receptors which are synthe- 
sized is either completely blocked or reduced In class 3 functionally 
defective receptors are formed. In class 4 the LDL receptors miss the 
ability to cluster in coated pits, which prevents them from being inter- 
nalized after binding LDL. In class 5 there is a failure in the delivery of 
LDL by receptors to endosomes or in recycling of LDL receptors to the 
cell surface (Thompson 1994, Schneider 1990). Until now, 150 different 
mutations have been described. Fifty four percent of them are class 2. FH 
occurs either in heterozygous form (inheritance of one mutant gene en- 
coding for the LDL receptor) or homozygous form (inheritance of two 
mutant genes). The latter occurs very rarelly. Heterozygous patients have 
plasma cholesterol levels between 9 and 11 mrnol/l’. Their triglyceride 
levels are usually in the normal range’, rarely beyond 4 mmol/l. Homozy- 
’ For comparison, the average plasma cholesterol for a midle-aged man 
in United Kingdom is between 6 and 6.5 mmol/l @urrington 1993) and the 
average plasma cholesterol in 50 years old Danes of both sexes is about 
6.5 mmovl (data from the Glostrup study (1982) mentioned in LST publi- 
cation nr. 176). 
?he normal range for humans is less than 2 mmol/l. 
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gous patients have total cholesterol levels about four times normal (Thomp- 
son 1994, Durrington 1993, Davignon 1991). Young men with homozy- 
gous FH may have heart attacks in their twenties. Less than 50% of affec- 
ted and not treated men survive to the age of 60. Most male survivors will 
have either a heart attack or angina pectoris by this age. The same applies 
to 50% of females with FH, although only 15% will be dead at the age of 
60 (Durington 1993). Apart from atherosclerotic lesions in the arterial sy- 
stem, tendinous xantbomas on the dorsum of the hands and the Achilles 
tendons develop in most of adult humans with FH. 
Another congenital condition leading to premature CHD despite the 
absence of the clinical features of FH is familial combined hyperlipidemia 
(FCH). The patients often have an increase in both plasma triglyceride and 
cholesterol levels and low levels of high density lipoprotein (HDL) chole- 
sterol. This condition often results from a synergy between the various 
adverse effects of risk factors such as hyperlipidemia, hypertension, diabe- 
tes and a family history of CHD. FCH is more loosely defined as FH but 
this condition is more common, affecting between 1 in 50 and 1 in 200 
people. 
I.C. THE USE OF ANIMALS IN ATHEROSCLEROSIS 
RESEARCH 
The information on pathogenic mechanisms on progression and regres- 
sion of atherosclerosis is gathered through experiments in animal models 
and studies in man such as intervention trials, epidemiological studies, and 
to some extent studies in patients. Additonally, various in vitro model 
systems to study different aspects of lipid and lipoprotein metabolism play 
important role in understanding of pathogenesis of atherosclerosis (Hussain 
et al. 1992). 
I.C.l. Advantages and limitations of human studies with respect to 
atherosclerosis 
The advantage of human studies is that they provide the direct infor- 
mation about the effect of a chosen factor on the human organism. Howe- 
ver, studies in man have several limitations. The intervention trials provide 
information on the short lasting effects of the treatment on clinical parame- 
ters (eg. blood lipids) only. Epidemiological studies are resource and time 
consuming and interpretation of the results is difftcult because of the 
multifactorial nature of the effect. The experimental approaches on human 
patients are limited by the difficulty to control the effect of the treatment. 
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The control is handicapped by .the slow rate of development/regression of 
the arterial lesions and the inability to make quantitative ante mortem de- 
termination of the extent and severity of the atherosclerotic lesions, because 
of the lack of noninvasive techniques that are sufftciently sensitive to 
measure the expected changes in the arterial wall of the arteries of greatest 
clinical interest, such as the coronary arteries. 
1X.2. Advantages and limitations of animal studies with respect to 
atherosclerosis 
To overcome some of the limitations of studies in man, the animal 
models are widely used in atherosclerosis research. There are several 
advantages of using animal models. The experiments on animals can be 
performed in relatively short time. They also permit the obtaining of 
information on a long lasting effect of the diet or treatment, because of the 
short life span of laboratory animals. The clinical results are supported by 
post mortem examination of the arterial system. The influence of environ- 
mental factors on the results is minimalized by standardization of labora- 
tory conditions and the use of the subjects with known genetic and health 
status (&wink & Rehbinder 1993). Furthermore, the studies in animal 
models are generally cheaper than most studies in man. 
In spite of obvious practical advantages the animal studies have a great 
limitation - the extrapolation from animal results to the human situation is 
dubious. The conclusions one can draw from experimental atherosclerosis 
are limited because the experimental atherosclerosis is usually produced by 
exaggerating a single risk factor eg. by atherogenic diet, while multiple risk 
factors of genetic and environmental origin are involved in the develop- 
ment of human atherosclerosis. Furthermore, the factum that the experi- 
mental lesions develop during a relatively short period in conditions of 
high or extreme hypercholesterolemia while human lesions develop over 
decades at much lower plasma cholesterol concentrations should be taken 
into consideration. It is also important to note that hypercholesterolemia 
induced by cholesterol feeding in most species is associated with unusual 
types of lipoproteins: p-very low density lipoproteins (p-VLDL) or large 
LDL which normally do not occur in significant quantities in man. 
I.C.3. Relevance of animal studies in atherosclerosis research 
The relevance of animal studies in atherosclerosis research is beyond 
doubt. The fact that the animal and human cells have in general the same 
structure (e.g. cell membrane) and biochemistry (e.g. glycolysis, p-oxida- 
tion, and the Krebs cycle) serves as the basis for extrapolation from animal 
results to the human situation (Calabrese 1983). The lipoprotein metabo- 
lism and the cholesterol metabolism at the cellular level are similar in man 
and laboratory animals despite some species differences e.g. the apopro- 
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tein(a) and the cholestetyl ester transfer protein (CETP) are absent in the 
mouse but present in man. The animal studies and investigations in man 
demonstrate the same response to known blood lipid lowering compounds 
and to dietary fats. Therefore, despite some differences in experimental 
atherosclerosis in laboratory animal models and the disease process in 
humans (I.C.2.), the studies in animal models provide reliable information 
on how different factors accelerate atherosclerosis. Furthermore, more 
definitive answers to the question on development and regression of at- 
herosclerosis in human have to await better techniques for noninvasive 
evaluation of atherosclerosis. Therefore the use of animal models continue 
to be critical for studies to uncover the cellular and biochemical events 
responsible for the development and regression of atherosclerotic lesions. 
Experiments in animals permit investigation of the biology of the arterial 
wall in each stage of plaque development and regression and under defined 
conditions. Although the effect of a diet or a therapeutic agent on the at- 
herosclerotic process in the arterial wall must ultimatively be demonstrated 
in humans, the primary screening has to be done in animals. The results 
from animal studies indicate direction for intervention trials and to some 
extent for epidemiological studies. Furthermore, they provide support for 
particular conclusions reached in the population studies. 
I.C.4. Most common animal models in atherosclerosis research 
The use of animal models in atherosclerosis research goes back to the 
beginning of this century. In 1908, Ignatovsky induced atherosclerosis in 
rabbits by feeding them milk, meat and eggs (Glueck 1979, Jokitten ef al. 
1985). In 1913, Anitschnikov obtained similar lesions feeding rabbits pure 
cholesterol (Glue& 1979). Since then different animal species have been 
used to study atherosclerosis (Vesselinovitch 1975, McCauley & Bull 1980, 
Malirwv 1983, Jokinen et al. 1985, Armstrong & Heistad 1990, Overt@& 
Loose-Mitchell 1992). The most common species have been: pigeons 
among birds, swine and rabbit among non-primate mammalians and Old 
World monkeys among non-human primates. The advantages and disadvan- 
tages of these models have been widely discussed (McCauley & BUZZ 1980, 
Jokinen et al. 1985, Armstrong & Heistad 1990, Overturf & Loose-Mitchell 
1992) and are summarized in the Table below (p. 16). Recently, the deve- 
lopment of transgenic techniques and identification of human genes coding 
for lipoprotein transport proteins opened the possibility to create various 
transgenic mice to study lipoprotein metabolism. Some of these transgenic 
mice seem promising animal models for atherosclerosis research (AaZto- 
SetiiZii 1992, BresZow 1993 & 1994, Maeda 1993, Rubin & Smith 1994, 
Mortensen 199.5). However, their commercial availability remains very 
restricted and their usefulness for atherosclerosis research is still under 
establishment. Thus until now, the rabbit has been the most popular anima.l 
model in atherosclerosis research (Mortensen et al. 1994). 
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Table: Advantages and disadvantages of four most common animal models 
of human atherosclerosis. 
Animal model Advantages Disadvantages 
Pigeon Lesions occur spontaneously, Plasma lipoproteins different 
can be exacerbated or in- from those in man. Topo- 
duced by dietary cholesterol. graphy of lesions different 
Morphological resemblance than in human. Herbivorous. 
of lesions to those in human. Avian. Reproduce slowly. 
Strain differences in suscep- Small size of body and ar- 
tibility to lesion formation teries. 
well established. 
Swine Lesions occur spontaneously, Lesions develop slowly. 
can be induced by atheroge- Large size”. Difficult to 
nit diet. Topography and handle. Expensive to main- 
morphology of lesions and tam. 
lipoprotein pmfile similar to 
those in human. Size of 
heart and vessels sufficient 
for studies of cardiovascular 
function. Omnivorous. 
Rabbit Experimental esions easily 
induced by dietary choles- 
terol. Spontaneous and in- 
duced lesions and blood li- 
pids well characterized. 
Strains developing sponta- 
neous atherosclerosis with 
morphological resemblance 
to that in humans available. 
Easy to acquire, maintain, 
relatively inexpensive. 
Herbivorous. Physiologically 
low plasma cholesterol com- 
pared to man. Topography 
of lesions different than in 
human. Exaggerated chole- 
stem1 feeding leads to 
extreme hypercholestem- 
lemia and lipid storage in 
many organs. 
Non-human 
primates 
Lesions occur spontaneously, Expensive to acquire and 
are exacerbated by dietary maintain. Long gestation 
cholesterol. Morphology of and few progeny. Most spe- 
lesions similar to those in ties are moderately resistant 
man. Lipoprotein profile si- to atherosclerosis. Species 
milar to human. Close phy- with small body size not 
logenetic relationship to suitable for collection of lar- 
humans. Omnivorous. ge blood samples. 
“:Tbis applies also to mini-pig which body weiht is relatively big compared 
to body weight of the pigeon, rabbit and most of the laboratory non-human 
primates. The body weight of 6 months old minigris is about 25 kg but a 
grown-up mini-pig may reach 50-70 kg (Skydsgaard 1988). 
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I.D. THE RABBIT MODELS IN ATHEROSCLEROSIS 
RESEARCH 
I.D.l. Suitability of the rabbit for ~atherosderosis research 
The suitability of an animal model in atherosclerotic research is evalua- 
ted based on three criteria: 1) the nature of atherosclerosis in the animal 
model, 2) biology of the chosen species, 3) features of the chosen species 
in the relation to the experimental procedure. 
The purpose of the criteria concerning the nature of atherosclerosis in 
the animal model is to ensure the resemblance of the experimentally in- 
duced or spontaneous disease in the model and that occurring naturally in 
man. This includes pathogenesis, morphological strucmre of lesions, their 
progression with time and topographical development as well as the occur- 
rence of the specific complications of the disease lie myocardial or cere- 
bral infarction, aneurysm, gangrene and loss of function of extremities. 
The present rabbit models fulfil the most important of these demands. 
Atherosclerosis in the rabbit models develops due to factors comparable to 
those existing in man e.g. due to exogenous factors such as diets (chole- 
sterol-fed rabbit model) or endogenous factors like genetic lipid disorders 
(e.g. WHHL rabbit, Kurosawa and Kusanagi rabbi? or St. Thomas Hospi- 
tal rabbit4). The atherogenic factors lead to development of atherosclerotic 
lesions in arterial wall. As in man the lesions in the rabbit progress in time 
from fatty streaks (i.e. subendothelial band-like accumulation of foam cells) 
to fibrous plaques (i.e. intimal thickenings with occasional foam cells) and 
advanced lesions (i.e. accumulation of foam cells in fibrous stroma with 
formation of deep seated plaque). Occasionally, the disease in the rabbit 
can be complicated by myocardial infarction, which, however, is due to 
atheromatous embolism in contrast to the usual atherothrombotic pathoge- 
nesis in humans. 
The shortcomings of the rabbit concerning the nature of atherosclerosis 
are the following differences from man: 1) topography of the lesions, 2) 
morphology of advanced lesions, 3) origin of hypercholesterolemia in 
cholesterol-fed rabbit and 4) extreme hypercholesterolemic response to high 
cholesterol and high fat diet. The rabbit mainly develops atherosclerotic 
lesions in the aortic arch and in the thoracic aorta and not in the abdominal 
aorta as in man. The complications of atherosclerotic plaques such as pro- 
nounced calcification, ulceration, haemorrhage and thrombosis leading to 
luminal stenosis never occur. The hypercholesterolemia in the cholesterol- 
fed rabbit occurs because the physiological mechanism of lipoprotein 
‘Kurosawa et al. 1995 in the reference list. 
4La Ville et al. 1987 and Seddan et al. 1987 in the reference list. 
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clearance are overwhelmed by large amount of dietary cholesterol while 
hypercholesterolemia in man is caused by genetic or acquired abnormalities 
in synthesis or degradation of plasma lipoproteins. If rabbits are fed high 
cholesterol (l-3% w/w or more) and fat diet @t-IO% w/w), they develop 
extreme hypercholesterolemia, lesions consisting mostly of lipid-laden ma- 
crophages and lipid infiltrations in different parenchymatous organs (e.g. 
IIID.: Mortensen et al. 1995). The extreme hypercholesterolemia and lipid 
infiltrations in different organs are a clinical and morphological manifesta- 
tions of disturbed lipid metabolism respectively. The disturbed lipid meta- 
bolism is considered as a disadvantage in an animal model to study the 
effect of dietary factors or drugs on atherosclerosis. This is because the 
massive hypercholesterolemia in the model may mask any effect of the test 
compound on blood lipid levels and (or) aortic cholesterol accumulation. 
However, the disturbed lipid metabolism due to high cholesterol and fat 
diet should be regarded as a failure in experimental design rather than a 
shortcoming of the rabbit itself. Concerning the morphology of atherosc- 
lerotic lesions in the cholesterol-fed rabbit the following should pointed 
out: the morphology of the lesions due to a reasonable atherogenic diet 
(cholesterol < 0.5%) is comparable to that of lesions induced in other 
species. In addition, none of the popular laboratory animal models of 
atherosclerosis, inclusive the rabbit models, develops atherosclerotic lesions 
identical to those in man. 
The purpose of the criteria concerning the biology of the chosen 
species is to ensure a well characterized biological organism for the study 
in order to facilitate the interpretation of the results. Therefore the demands 
are directed towards defined genetic background, similarities between the 
species and man in anatomy, physiology, clinical chemistry and function of 
the cardiovascular system, to the availability of the information on physio- 
logical levels on blood lipids, spontaneous and induced atherosclerosis in 
the species, and possible strain differences in response to atherogenic 
Stimuli. 
The rabbit models fulfii most of these demands. The genetics, physio- 
logy and pathology of the rabbit is well known. The physiological levels of 
blood lipids in normolipidemic and spontaneously hypercholesterolemic 
rabbits have been described (FiZZos & Mann 1956, Roberts et al, 1974, 
Watanabe 1980, Lind et al 1990, Norih et al. 1993, Esper et al. 1993a, 
La ViZZe et al. 1987, Have1 et al. 1982). The normohpidemic rabbit and 
man are both “LDL mammals” which means that the sum of the VLDL, in- 
termediate density lipoproteins (IDL), and LDL accounts for more than 
50% of the total plasma lipoproteins in both species. Lipoprotein metabo- 
lism in the rabbit bears some important resemblances to that of humans: 1) 
apo B-100 is the major or sole form of apo B secreted in the liver, 2) an 
active mechanism for transfer of cholestetyl esters between lipoproteins 
also exist in the rabbit and 3) the LDL receptor in the rabbit is readily 
regulated by diet and drugs that also affect the activity of the hepatic LDL 
receptors in humans (Havel et al. 1989). The spontaneous atherosclerosis in 
normolipidemic rabbits and in spontaneously hypercholesterolemic rabbits 
(WHHL and St. Thomas Hospital rabbits) has been described (Haunt & 
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More 1965, Schenk et al. 1966, Buja et al. 1983, Rosenfeld et al 1987 ab, 
Sedan et al. 1987, III&: Hansen et al. 1994). The experimental at- 
herosclerosis due to cholesterol feeding has been characterized by light 
microscopy (Constantinides 1965, Pollack 1965, Lee et al. 1978). The stra- 
in and age variations in response to cholesterol diet have been described 
(PoZZack 1965, Spagnoli et al 1991). 
The most frequently mentioned shortcomings of the rabbit concerning 
the biology are that 1) the rabbit is herbivorous while the man is omni- 
vorous, and 2) the rabbit has physiologically low plasma cholesterol com- 
pared to man. Among the physiological differences in lipid metabolism 
between the rabbit and human a reduced activity of hepatic lipase and 
lower conversion of VLDL to LDL, and a higher activity of cholesteryl 
ester transfer protein in the rabbit compared to man should be noted. The 
fact that the major carrier of the plasma cholesterol in the cholesterol-fed 
rabbit is p-VLDL while it is LDL in man, is no longer regarded as a 
shortcoming of the model because a comparable condition also occurs in 
man known as broad-p disease (type II hyperlipidemia) (Overt& & Loose- 
Mitchell 1992). 
The purpose of the criteria concerning the features of the chosen 
species in relation to experimental procedure is to facilitate the realisation 
of the experiment. The animals should have a proper size to allow the 
desired blood sampling frequency and total volumen of a single sample, the 
experimental manipulation e.g. angiography, histological examination of the 
aorta and also the coronary arteries. The induced lesions or lesions due to 
inherited hypercholesterolemia ,should develop in relatively short time to 
enable a reasonable duration of the experiment. Animals should be easy to 
acquire, handle and house, especially when large number of animals is 
needed, and of reasonable cost. The rabbit fulfils most of these demands. 
I.D.2. Reasons for choosing the rabbit for this project 
As presented above the rabbit fulfils most of the criteria for an animal 
model in atherosclerosis research. Some of the shortcomings such as dif- 
ferent topography of the lesions and lack of complications of the advanced 
lesions specific for the man also exist in other animal species, and they are 
of minor importance compared to the fact that the rabbit and man share 
common points in the mechanism of lesion formation. The shortcoming 
that the rabbit is herbivorous and that the normolipidemic strains have 
lower plasma cholesterol than man became less important when spontane- 
ously hypercholestemlemic rabbit strains were developed. Thus, keeping in 
mind the demands torwards the nature of atherosclerosis in a laboratory 
animal model and torwards the biology of the chosen species, the advanta- 
ges arising from the features of the chosen species in relation to experi- 
mental procedure, and the capacity of the animal facilities in our labora- 
tory, the rabbit was chosen to investigate links between the dietary fats and 
atherosclerosis in this project. Also of great importance for this decision 
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was the opportunity to obtain WHHL rabbits, not commercially available at 
that time, for the study of the development of spontaneous atherosclerosis 
with the intent of using this strain for dietary and medicamental interven- 
tion in the future. 
I.D.3. Characteristic features of the rabbit models chosen in the pro- 
ject 
The cholesterol-fed rabbit 
The cholesterol-fed rabbit, based on physiologically normolipidemic 
strains is a classical rabbit model. Due to exogenous cholesterol added to 
the diet the rabbits develop hypercholesterolemia with the p-VLDL as the 
major carrier of plasma cholesterol and atherosclerotic lesions. The 
atherosclerotic lesions have fibrocellular morphology when caused by low 
cholesterol doses (0.1-0.3 g/rabbit/day). The higher cholesterol doses lead 
to extreme hypercholesterolemia, formation of lesions consisting of lipid 
laden macrophages, and extracellular lipid infiltration in parenchymatous 
organs. This rabbit model is widely used to study the role of dietary factors 
in the development of atherosclerosis, the lipoprotein metabolism and for 
screening of hypocholesterolemic compounds. This rabbit model has been 
chosen to study effect of hydrogenated fat on development of experimental 
atherosclerosis in this project (IILC.). 
Homozvgous Watanabe heritable hvuerlipidemic rabbit 
This rabbit strain was obtained by inbreeding from a single hyperli- 
pidemic mutant discovered in 1973 by Watanabe (Kondo & Watanabe 
197.5). These rabbits are genetically deficient in LDL receptors and have 
strong hypercholesterolemia, moderate triglyceridemia, and spontaneously 
develop atherosclerosis. The LDL receptor deficiency is inherited as a 
single gene mutation. Cholesterol synthesis, concentration, composition and 
metabolism of lipoproteins and morphology of arterial atherosclerosis have 
been intensively studied in this rabbits (Dietschy et al. 1983, Have1 et al. 
1982, 1989, Buja et al. 1983, Goldstein et al. 1983, IIIB.: Hansen et al. 
1994). Several similarities between the disease process in homozygous 
WHHL rabbits and humans with FH have been established. In these ani- 
mals and FH patients 1) the massive hypercholesterolemia results from a 
defect in the gene for LDL receptor, 2) the lipoproteins that carry endo- 
genous cholesterol are elevated (LDL, IDL, VLDL) while the lipoproteins 
that carry dietary (=exogenous) cholesterol are at normal levels (chylomi- 
crons), 3) the HDL cholesterol may be at normal or reduced level com- 
pared to physiological levels, 4) the arterial atherosclerosis develops and 
progress with age. Furthermore, 5) the morphology of atherosclerotic 
lesions in homozygous WHHL rabbits closely resemble that of human athe- 
rosclerotic lesions, 6) and tendinous xanthomas were reported also in the 
homozygous WHHL rabbits. The difference between the FH in humans and 
the disease process in homozygous WJIIIL rabbits is the presence of trig- 
lyceridemia in the rabbits and its absence in man. This difference originates 
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from the species difference in lipoprotein metabolism: the rabbit LDL has 
a relatively high triglyceride content in comparison to human LDL. The 
homozygous WJX-IL rabbit has been used to study the development and 
progression of atherosclerotic lesions (Rosenfelcf et al. 1987 ab), and for 
dietary and medical interventions (Clubb et al. 1989, Lichtenstein & Cho- 
banian 1990, Carew et al. 1987, Nagano et al. 1989, Mao et al. 1991, 
Mortensen et al. 1995). Until recently the WHHL rabbits were not com- 
mercially available. The colonies existed only in a few laboratories. This 
rabbit model has been used in this project to monitor blood lipids in gro- 
wing and adult rabbits (III.A.l.-2.), to study the morphology of sponta- 
neous atherosclerosis (1lI.B.) and for dietary and drug interventions (II1.E. 
& IILF.). 
The cholesterol-fed heterozvgous WIWL rabbit 
Heterozygous WHHL rabbits have plasma cholesterol levels signi- 
ficantly lower than their homozygous siblings. The levels are comparable 
to the levels in normolipidemic rabbits (Esper et al. 1993 a, ZZI.A.1. & 2.) 
or intermediate between those in normal rabbits and those in WHHL 
homozygotes (Goldstein et al. 1983). The heterozygous WHHL rabbits 
develop only minimal spontaneous atherosclerosis observable at the age of 
approximately two years (Atkinson et al. 1989, Esper et al. 1993 b, IIIB.: 
Hansen et al. 1994). Analogously to the normolipidemic rabbits cholesterol 
feeding leads to hypercholesterolemia and to development of experimental 
atherosclerosis. The high cholesterol doses induce disturbances in the lipid 
metabolism manifested by extreme hypercholesterolemia and extravascular 
lipid deposition in various organs (IBID.: Mortensen et al. 1995). Further- 
more, the high cholesterol and the high fat diet may lead to severe liver 
changes (Simonsen et al. 1995). The morphology of atherosclerotic lesions 
is fibro-cellular. These lesions are not too different from the spontaneous 
lesions in 6 months old homozygous WHHL rabbits (Atkz’nson et al. 1989, 
IUD.: Mortensen et al. 1995) and from lesions seen in cholesterol-fed 
rabbits receiving low doses of cholesterol (II1.D.: Mortensen et al. 1995). 
The cholesterol-fed heterozygous WHHL rabbit was proposed as a new 
rabbit model in atherosclerosis research in 1989 (Atkinson et al. 1989). 
However, the use of this model seems very limited as no reports from 
other laboratories have been published until now. In our laboratory the 
heterozygous WHHL rabbit fed low cholesterol doses has been used to 
study the atherogenic effect of different fats (Andersen et al. 1993, Morten- 
sen et al. 1994). In this project the heterozygous WHHL rabbit fed 1% 
cholesterol was tested as a model for investigations of atherogenic effect of 
dietary fats (IILD.) 
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ILA. INDUCTION OF EXPERIMENTAL ATHEROSCLEROSIS 
IN CHOLESTEROL-FED RABBIT 
II.A.l. Methods for cholesterol addition to the rabbit diet 
Experimental atherosclerosis in the cholesterol-fed rabbit is induced by 
addition of exogenous cholesterol to the diet. There are several methods for 
addition of cholesterol to the diet A tirst method is dissolving the choles- 
terol in a solvent e.g. chloroform (Ktirchevsky 1970) or ethyl ether (Lerh- 
Espemen er al. 1988) and pouring it on the pelleted rabbit diet and mixing 
them thoroughly. When the solvent evaporates the cholesterol added diet is 
ready for use. This method allows preparation of a so called cholesterol 
“fat-free” rabbit diet. This means that the diet does not contain any addi- 
tional fat but only the fat which is a native component of standard rabbit 
chow’ (Krifchevsky 1970). A second method is dissolving cholesterol in 
the test fat(s) and adding it (them), with continuous mixing, to the pelleted 
rabbit diet. The mixture of fat and cholesterol is usually heated to facilitate 
the dissolving of cholesterol. A third method is suspending cholesterol in 
the test fat(s) and adding the suspension, with continuous mixing, to the 
rabbit pelleted diet. A fourth method is addition of cholesterol to the pow- 
dered standard rabbit diet and pelleting afterwards. This method allows 
preparation of so called cholesterol “fat-free” diet to which test fat(s) can 
be added, if necessary. Addition of the fat is done by pouring the fat on the 
pellets and mixiug thoroughly. This method was used in this project (II1.C. 
& D.). 
An important point was raised by Kritchevsky (1970) concerning the 
differences in atherogenic potential of the same cholesterol dose added to 
the diet as a suspension in the fat or dissolved in me same type of fat. The 
heating of some fats in order to facilitate dissolution of cholesterol in them 
increases the content of free fatty acids in these fats and their atherogeni- 
city. For instance this is the case for corn oil but not for olive oil. Thus 
the diet added cholesterol dissolved in a test fat may be more atherogenic 
than the diet containing cholesterol suspension in this test fat This should 
be kept in mind when designing experiments. 
II.A.2. Cholesterol feeding regimens 
There are different methods for dosing the rabbits with cholesterol in 
the diet in order to induce experimental atherosclerosis. The following 
classification of the methods is proposed: 1) fixed single cholesterol level 
‘The fat content in standard rabbit diet is 2-5% (Hagen 1974). 
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regimen, 2) controlled one cholesterol level regimen, and 3) controlled 
individual cholesterol dose regimen. 
Fixed single cholesterol level regimen is a classical design for induc- 
tion of experimental atherosclerosis in the rabbits. All groups receive the 
same fixed dose of cholesterol in the diet during the whole experimental 
period regardless of dietaty or medicamental treatment. The hypercholes- 
terolemia is not controlled deliberately but in exueme cases of unsatisfac- 
tory changes in plasma cholesterol (to high or to low increase) the dose 
may be changed. This design allows to study the effect of treatment on 
plasma lipids and experimental atherosclerosis. This regimen preceded by a 
4 weeks adaptation period to experimental diets was used to induce experi- 
mental atherosclerosis in heterozygous WHHL rabbits in order to study its 
morphological picture in aorta and to compare effect of n-6 and n-3 
polyunsaturated fatty acids in this project @I.D.). 
Controlled one cholesterol level regimen is a modification of the first 
method. All groups receive the same cholesterol dose as the control group. 
The cholesterol dose for the control group is adjusted at an interval of a 
few days in order to maintain the mean plasma cholesterol in this group at 
a certain predetermined level. This method prevents the unsatisfactory 
changes in plasma cholesterol which may occur using the fixed single 
cholesterol level regimen. This design also allows to study the effect of 
treatment on plasma lipids and experimental atherosclerosis. This regimen 
has been used in our laboratory to induce experimental atherosclerosis in 
hetemzygous WHHL rabbits in order to compare the athemgenic effect of 
different fats (Andersen et al. 1993, Mortensen ef al. 1994) but it was not 
used in this project. 
Controlled individual cholesterol dose regimen is more resource con- 
suming. All rabbits regardless of the treatment group receive individual 
cholesterol doses which are adjusted at an interval of a few days in order 
to maintain all the rabbits at the same plasma cholesterol level chosen for 
the study. This regimen diminishes the differences in hypercholesterolemic 
response to exogenous cholesterol between hypo- and hyper-responders. It 
allows to study the effect of test compounds on distribution of plasma 
cholesterol between lipoproteins and on experimental atherosclerosis due to 
other mechanism than a change in total plasma cholesterol. This regimen 
has been used to induce experimental atherosclerosis in normolipidemic 
rabbits used in drug trials (Hoh ef al. 1995) to compare the atberogenic 
effect of different fats (Lefh-Espensen et al. 1988) and olive oil and mar- 
garine in this project @EC.). 
The duration of cholesterol feeding varies in different studies depend- 
ing on the aimed degree of atherosclerosis and the type of lesions. In 
general, the low cholesterol doses e.g. O.l-0.3% are applied for several 
weeks in order to obtain the fibrocellular atherosclerotic lesions in aorta. 
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II.B. BREEDING OF WHHL RABBlTS 
All WHHL rabbits in this project were obtained from own breeding 
colony established in 1990 from a parent generation obtained with the 
permission of dr. Y. Watanabe from Prof. Jansen, University of Leiden, 
The Netherlands. 
The LDL receptor deficiency in WHHL rabbits is inherited as a single 
gene mutation. This is a simple Mendelian trait with partial expression in 
the heterozygous state and complete expression in the homozygous state. 
All offspring of homozygous parents inherit the LDL receptor deficiency. 
The offspring of heterozygous WHHL parents are of different genetic 
status: free for LDL receptor deficiency, heterozygotes for LDL receptor 
deficiency and homozygotes for LDL receptor deficiency in the ratio 1:2: 1 
respectively. The offspring of homozygous parent and the heterozygous 
parent are either homozygotes or heterozygotes for LDL receptor deticien- 
cy in the ratio 1:l. All the offspring of homozygous parent and normoli- 
pidemic parent are heterozygotes for LDL receptor deficiency. 
The breeding of WHHL rabbits using homozygous parents is difficult 
as homozygous WHHL females show decreased reproductive performance 
compared to heterozygous WHHL females or normolipidemic females 
genetically free for LDL receptor deficiency (IZIAl., Shiomi et al. 1987). 
Additionally, frequent occurrence of stillbirths in homozygous WHHL 
females and birth deformities of the offspring has been reported (&per et 
al. 1993). A few cases of pregnancy toxemia (Be&all & Dysko 1994) and 
decreased conception rates in homozygous WHHL females were seen in 
our breeding colony. The heterozygous LDL receptor deficiency condition 
in WHHL females does not significantly affect the reproductive perfor- 
mance compared to normolipidemic females (111.A.I.). Therefore mating of 
homozygous WHHL males with heterozygous WHHL females is the 
preferred system to obtain the homozygous offspring in our colony while 
heterozygous WHHL offspring were obtained either of homozygous males 
with New Zealand White (NZW) females or heterozygous WHHL females. 
Comparison of the reproductive performance of homozygous and hetero- 
zygous WHHL and New Zealand White breeding females from our colony 
is presented in Table 1 in chapter III.A.l. 
The distinction between the heterozygous and homozygous offspring 
obtained from homozygous WHKL males and heterozygous WHHL 
females is based on the total plasma cholesterol level which is measured at 
4 weeks of age @reliminary selection) and 6 weeks of age (final selection 
at the end of weaning) in our colony. All offspring with a total cholesterol 
higher than 10 mmol/l at the end of weaning is considered homozygous. 
The distinction between homozygous and heterozygous WHHLs based on 
the plasma cholesterol level at the end of weaning is applied in several 
laboratories (Shiomi et al. 1987, Rich et al. 1989, Esper et al. 1993). 
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H.C. MEASUREMENT OF BLOOD LIPIDS 
Determination of blood lipids includes measurement of the concentra- 
tion of total cholesterol, triglycerides and assay of the concentration of 
cholesterol and triglycerides in lipoproteins. The results are expressed as 
mmohl. In some countries the concentration of blood lipids is still 
expressed in mg/dl’. In this project, the blood lipids were measured in 
plasma. Therefore, all blood samples ‘were collected into tubes containing 
EDTA or naaium heparinat. Then the blood samples were centrifuged for 
10 min at 4000 rpm in order to separate plasma from blood cells. 
II.C.l. Measurement of total plasma cholesterol 
In this project the measurement of total plasma cholesterol was per- 
formed automatically in a COBAS MIRA autoanalyzer using CHOD-PAP 
(Boehring Mannheim) method based on an enzymatic colorimeuic test 
(Seidel et al. 1983, Kattermannet al. 1984) the principle of which is pres- 
ented below: 
Five pl plasma was added 35 pl H,O and 350 pl reagent MPR2 CHOL 
1442341 (total volume 390 pl) and the extinction was measured at 500 nm. 
The reagent MPR2 CHOL 1442341 was prepared before the measurement: 
the content of the bottle with the reagent was added 100 ml of MiliQ water 
and placed for 10 min at room temperature. The Roche lipid control serum 
art. nr. 0737194 was used for calibration. The coefficient of variation 
within the day is 0.8% (n=25) and the, coefficient of variation beween days 
is 4.7% (n=7). 
II.C.2. Measurement of total triglycerides 
In this project the measurement of triglycerides was performed auto- 
matically with a COBAS MIRA autoanalyzer. The analysis is based on an 
‘Conversion of values from mg/dl to mmol/l: for cholesterol divide mg/dl by 
38.7, for triglyceride divide md/dl by 88.5. Conversion of values from mmol/l to 
m@ll: for cholesterol multiply mmol/l by 38.7, for triglyceride multiply mmovl 
by 88.5. 
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enzymatic colorimeuic test GPO/PAP. This test is performed using the 
Unimate TRIG, an in vine diagnostic reagent system (Hoffman La-Roche). 
The principle of the method is as follows: 
ll+&xdles a glycero+faayacils 
Glyceml+AIP & glyxml-3-p+- 
Glyml- 3 - P + 02 cpo. dinydmyacetone phoqhte + Hz02 
In presence of peroxidase, the hydrogen peroxide formed affects the oxida- 
tive coupling of 4-chlorophenol and 4aminoantipyrine to form a red 
coloured quinoneimine derivative. The colour intensity is directly related to 
the triglyceride concentration and is measured photometrically. 
Four pl plasma was added 36 pl Ha0 and 300 pl reagent (total volume 340 
~1) and red at 500 nm. The reagent Unimate 5 was prepared before the 
measurement: the content of the bottle with the reagent was added 30 ml 
MiliQ water and placed in room temperature for 10 mm. The Roche lipid 
control serum art. N. 0737194 was used for calibration. The coefficient of 
variation within the day is 1.9% (n=25) and the coe’ricient of varation 
between the days is 2.9% (n=lO). 
Fig. 2. Lipoprotein fractions in plasma from NZW rabbit 
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II.C.3. Measurement of total cholesterol and triglycerides in 
lipoproteins 
In this project, the lipoproteins were separated by density gradient 
ultracentrifugation by the method of Terpstra et al. (1989). Kalium bro- 
mide (KBr Merck 4905) 228 mg and 50 mg sucrose @(+)-saccharose Roth 
4621.1) were placed in each ultracentrifuge tube. Subsequently 2 ml of 
plasma was pipetted into each tube and finally 0.2 ml of Sudan black 
(Sudan Schwartz B Serva 35610) solution was added to prestain the plasma. 
Thereafter the content of each tube ivas overlayered with 4.8 ml MiliQ 
water. The tubes were cenuifngated for 18 h at 84000 x g, = 112000 x 
&- at room temperature. After the centrifugation five layers were seen in 
each tube (Fig. 2). Starting from the bottom, the first fraction was HDL, 
the third LDL, the fourth IDL and the fifth HDL. The second fraction was 
not used in the assay. The density ranges of isolated fractions were: VLDL 
p<1.0063 &al, lDL 1.0063<p<1.019 g/ml, LDL 1.019<p<1.063 g/ml, 
HDL 1.063<p4.21 g/ml. The fractions were removed from the tube separ- 
ately. The content of cholesterol and triglycerides in each fraction was 
determined as described above (KC.1 and lI.C.2). 
II.D. EVALUATION OF ATHEROSCLEROSIS 
Atherosclerosis in the rabbit can be evaluated by macroscopic, microscopic 
and biochemical methods. 
II.D.l. Macroscopic quantitative evaluation 
Macroscopic quantitative evaluation measures disease extent. It is per- 
formed on longitudinally opened aorta using different methods. 
Naked eve evaluation, In this method the extent of atherosclerotic 
lesions in the aortic intima is estimated visually and usually it is performed 
separately in the ascending, the thoracic and the abdominal parts (Fig. 3). 
The estimation is performed on fresh tissue in connection with the autopsy. 
Different grading systems are used. Wu et al. (1988) estimated the extent 
of atheromatous plaques in the intima in these three parts of aorta using a 
four grade system: grade 0 indicated no lesions present, grade 1 indicated 
focal distribution of lesions, grade 2 indicated that less than 50% of aorta 
is covered by lesions, and grade 3 indicated that more than 50% of area is 
covered by lesions. Nordestgaard & Lewis (1991) used a more detailed 
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grading system. The area of the aortic intimal surface covered by lesions 
was graded visually as 0, 2, 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, and 
100%. Then the average percent for the whole aorta was calculated. In this 
project, the extent of atherosclerotic lesions in the intima of the ascending, 
the thoracic and the abdominal aorta was recorded at 5% intervals and it 
was always performed by the same person @LB.). 
The advantage of naked eye evaluation is that 1) it is performed immedi- 
ately after euthanasia, 2) it is not time consuming, 3) it demands no 
advanced instruments, and 4) it leaves the “intact” aortic tissue for other 
and more advanced procedures e.g. histology or biochemical analysis. The 
disadvantage of this method is that it is subjective. The use of a more 
detailed grading system can give rise to a divergence in the evaluation of 
the extent of atherosclerosis. Therefore the estimation should be performed 
by the same person in the same study. 
1 2 3 I5 6‘7 
Fig. 3. Macroscopic picture of aordc atherosclerosis in longitudinally 
opened aorta from 19 months old homozygous WI-EL male rabbit. a: 
ascending aorta, b: thoracic aorta, c: abdominal aorta. 
Evaluation of lipid uositive areas. Quantitation of aortic lipid positive 
area can be done on the whole aorta or separately in its ascending, thoracic 
and abdominal parts. Directly after removal from the body the aorta is 
opened longitudinally, pinned endothelial side up, photographed, and fixed 
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in formalin. After fixation the aorta is stained with Sudan IV - the lipid 
positive areas become red - and the vessel is photographed again. The 
photographs are used to estimate the extent of sudanophilia by planimetry 
using a computer assisted planimetry system. The results are expressed as 
percent of total surface area covered by plaques, This method is used not 
only in the rabbit (Atkinson et al. 1989, Clubb et al. 1989, Rich et al. 
1989) but also in swine (Cornhill et al. 1985) and in mice (Palinski et al. 
1994). This method is more objective than naked eye evaluation. It is also 
a relatively quick method as the calculation of the results is done using 
computer assistance. This method was not used in this project. 
Point-counting. The ascending, thoracic and abdominal parts of aorta 
are photographed. The pictures of aortic parts are covered with the trans- 
parent point-grid. The number of points hitting atherosclerotic lesions (P- 
lesions) and the number of points hitting the whole aortic surface (P-aorta) 
on the photograph are recorded. The percent intima with lesions is then 
calculated: P-aorta/P-lesions x 100. This method was used in this project 
(BIB.). 
II.D.2. Microscopic qualitative and quantitative evaluation 
Qualitative evaluation. In this project the qualitative evaluation in parts 
ILB., BID., 1II.E. and BID. was performed as recording of three types of 
atherosclerotic lesions: 1) fatty streaks i.e subintimal accumulation of foam 
cells, 2) fibrous plaques i.e. localised intimal thickenings with occasional 
foam cells, and 3) advanced lesions i.e. intimal thickenings with many 
foam cells and or cholesterol crystals usually localized in deep-seated 
pools. In III.C. a qualitative estimation of atherosclerotic lesions in aorta 
and other chosen arteries was done using the following graduation: 0: not 
present, +: slight changes, ++: moderate to severe changes. 
Ouantitative evaluation. This evaluation is a measure of the severity 
and extent of atherosclerosis. The microscopic quantitation of 
atherosclerosis was performed by point-counting in this project @LB., 
IILC., IKE., ELF.). The microscopic picture of transversely cut arteries 
stained with elastic-van Gieson or elastic Hematoxylin-eosine was projected 
to point-counting grid. The grid shows regularly spaced points on a white 
background. The extent of an atherosclerotic lesion is quantitated by count- 
ing the number of points hitting the lesion. The degree of magnification of 
the microscopic picture and the distance between the points in the grid are 
constant. Quantitation was performed in two to four serial sections of the 
artery, and the result was recorded as a mean value of counting results. 
Aorta. In cross sections of unopened ascending, thoracic and abdominal 
aorta the points covering the intimal lesions (P-intima) and points covering 
media of the aottic wall (P-media) were recorded. The severity of 
atherosclerotic lesions was then calculated as ratio R = P-intima/P-media 
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(Ratio I/M). Furthermore, the severity of an atherosclerotic lesion was 
recorded in size of lesion in mm’. This calculation is based on knowledge 
of both exact degree of magnification of the microscopic picture and of 
exact distance between points in the grid. In our estimation 1 mm of arter- 
ial tissue was magnified to 2.1 cm on the grid where points were regularly 
placed 1 cm apart. According to the formula: 1 point = 1 x 1 / 2.1 x 2.1 = 
0.227 (Gundersen et al. 1988) the quantitation recorded in points could be 
converted into mm’. 
.I& coroMly artery. The degree of l&al stenosis in regular cross- 
sections of the left coronary artery was estimated as described below. In an 
artery without atherosclerotic lesions the internal elastic lamella is the 
demarcation of arterial lumen. This area is quantitated (P-IEL: number of 
points covering the total area luminal to the elastic lamella). In the diseased 
artery there is a reduction in size of lumen - this reduced lumen is quanti- 
tated (P-lumen: the number of points covering the free luminal space ). The 
percentage stenosis was then calculated: % stenosis = (1 - P-lumen / P- 
IEL) x 100. 
Fig. 4. Typical fatty saeak in aorta of homozygous WHHL rabbit: suben- 
dothelial band-like accumulation of foam cells (Elastin van Gieson, x 100) 
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Fig. 5. Typical fibrous plaque in aorta of homozygous WHHL rabbit: 
localized intimal thickenings with occasional foam cell (elastin van Gieson, 
x 40). 
Fig. 6. Typical advanced lesion located where elastic (aortic) artery 
changes into muscular (coronary) artery in WHHL rabbit: accumulation of 
foam cells in fibrous stroma with formation of deep seated plaque (elastin 
van Gieson, x 100). 
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Right coronary army. The degree of atherosclerotic lesions in longi- 
tudinal sections from the first part of the right coronary artery was also 
estimated by point counting technique. The point-grid was circular. We 
know (IILB.: Hansen et al. 1994) that lesions are most pronounced exactly 
where the arterial wall changes from elastic type (aorta) to muscular type 
(coronary artery, see Fig. 3b in BIB). The quantitation was performed in a 
restricted area, the centre of which was defined as this shift in arterial wall 
structure. Points covering the intimal lesion (P-i&ma) and points covering 
the media (P-media) were recorded and used to calculate the ratio I/M. The 
severity of an atherosclerotic lesion was also recorded in size of lesion 
mm* (see above). 
H.D. 3. Biochemical determination of cholesterol content in aorta 
This quantification of aortic atherosclerosis is regarded as a combined 
measurement of atherosclerosis extent and severity. In this project, the 
aortic specimens containing aortic intima-inner media from ascending, 
thoracic and abdominal aorta were minced with scissors and the lipids were 
extracted with 20 volumes of chloroform/methanol 2:l or 1:l (v/v) during 
24 h. Lipids in the supematant and proteins in the precipitate were separ- 
ated by the method of Fokh et al. (1957). Total cholesterol was deter- 
mined by the Liebermann-Burchard method after saponification (Ness et al 
1964). The amount of protein was determined by the method of Lowry ef 
al. (1951). The results were presented either as nmol cholesterol per mg 
wet weight and nmol cholesterol per mg protein (IILC.) or pmol cholesterol 
per cm* aorta @LB.) or mg cholesterol per g tissue (IKE.) depending on 
the study. 
H.E. BASIC FEEDING REQUIREMENTS OF THE RABBIT AND 
FEEDING SYSTEMS 
Rabbits are usually fed a pelleted diet made up of grains, hay and 
certain supplements (Hagen 1974, Hunt & Harrington 1974). According to 
Hagen (1974) rations of maintenance or breeding diet should provide the 
following: 
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Maintenance diet* Breeding die? 
Crude protein % 12-15 16-20 
Fat % 2-3.5 3-5.5 
Fiber % 20-27 15-20 
Nitrogen-free extract % 43-47 44-50 
Ash or minerals % 5-6.6 4.5-6.5 
I: Rations for dry does, herd busks and growing rabbits. 
a: Rations for pregnant or lactating females. 
The rabbit diet most commonly used in our laboratory is Altromin 
2110 (Altromin Tier-Labor-Service, D-4937 Lage, Germany). The composi- 
tion of Altromin 2110 is as follows: 
Crude protein 15.0% 
Crude fat 3.5% 
Crude tiber 19.5% 
Ash 8.0% 
Moisture 12.0% 
Nitrogen-&e-extract 42.0% 
This diet in a pelleted form is referred to as Altromin 2113 and as a pow- 
der it is referred to as Ahromin-2111. For content of vitamins, amino acids, 
minerals and trace elements see Appendix (~~44). 
There are two systems for feeding the rabbits: 1) restricted feeding and 
2) feeding ud Zibifwn. In the first system the rabbits receive a measured 
amount of feed each day. This system permits recording of the feed intake. 
Therefore this system is usually applied in dietary studies. In the second 
system the daily portions are not limited. 
In this project, the rabbits had free access to tap water and were fed 
once daily. The type of feed and size of the daily ration depended on the 
study design and were stated in “methods” section under each study. 
ILF. HOUSING AND CLINICAL OBSERVATION OF RABBITS 
In this project, all the rabbits from the 6 weeks of age were housed 
individually in steel cages under controlled environmental conditions. The 
temperature was maintained at 18 f 2’C. The relative humidity was 55- 
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65%. The light was on from 8:00 to 2O:OOh. The body weight of rabbits in 
experiments was recorded once weekly. Ail the rabbits were observed ar 
least twice a day for any abnormalities in the clinical condition. 
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III. A. REPRODUCTION AND PHYSIOLOGICAL BLOOD LIPID 
LEVELS IN GROWING AND ADULT NORMOLIPIDEMIC 
AND SPONTANEOUSLY HYPERLIPIDEMIC RABBITS 
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lipidemic and New Zealand white rabbits 
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SUMMARY 
The aim of the study was to compare the reproductive performance of 
homozygous and heterozygous WHHL and NZW females, to record the 
changes in blood lipids due to gestation and lactation in the heterozygous 
WHEIL and NZW females, and to investigate the changes in blood lipids 
from 4 to 11 weeks of age in homozygous and heterozygous WHHL and 
NZW rabbits. The conception rate of homozygous WHHL females was 
14% lower than that of NZW and heterozygous WHHL females. The litter 
size and the weaning rate of homozygous WHHL females were significant- 
ly lower than in NZW and heterozygous WHHL females. In heterozygous 
WHHL and NZW females the total cholesterol was lower during the 
gestation and lactation while the triglyceride level was higher during the 
gestation and was lowest during lactation when compared to the levels at 
mating. In growing homozygous WHHLs of both sexes the total cholesterol 
did not change from 4 to 11 weeks of age. The triglycerides remained 
unchanged in males but decreased in females at 11 weeks of age. At this 
age the triglycerides were significantly lower in females than in males. In 
growing heterozygous WHHLs of both sexes the total cholesterol and 
triglyceride level decreased with age. At 11 weeks of age the blood lipids 
were significantly higher in females than in males. The triglyceride levels 
in homozygous and heterozygous WHHL males and females were compar- 
able at 4 and 6 weeks of age but were significantly lower in heterozygous 
WHHLs at 11 weeks of age. In growing NZW rabbits of both sexes the 
blood lipids decreased significantly with age but no sex difference was 
recorded. The blood lipids in the heterozygous WHHLs of both sexes were 
higher than in NZWs during the weaning. At 11 weeks of age the blood 
lipids of the males and triglycerides of the females of both strains were 
comparable. Only the total cholesterol remained higher in heterozygous 
WHHL females. The decrease with age in blood lipids in growing rabbits 
should be kept in mind when designing experiments beginning in animals 
younger than 3 months of age. 
Key words: WHHL rabbit, blood lipids, reproductive performance, hyper- 
lipidemia 
INTRODUCTION 
The homozygous Watanabe heritable hyperlipidemic (WHHL) rabbit is 
an animal model for human familial hypercholesterolemia. This strain was 
developed by Watanabe (Wurunube 1980) from a male mutant Japanese 
white rabbit. The mode of inheritance of the trait is recessive. The homozy- 
gous animals have a reduced number of functional low density receptors, 
they exhibit strong hypercholesterolemia and moderate niglyceridemia and 
spontaneously develop atherosclerosis. Their atherosclerotic lesions are well 
characterized (Buja et al. 1983, Rosenfeld et al. 1987 ab, Fischer Hansen 
1994) and are considered to be a close approximation of human lesions. 
The heterozygous WHHL rabbits have blood lipid levels as other normoli- 
pidemic rabbits and develop only minimal spontaneous atherosclerosis 
which is not observed until the age of approximately 2 years (Atkinson et 
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al. 1989, Esper et al. 1993b, Fischer Hansen et al. 1994). The WHHL 
rabbits have been used in dietary and medicamental intervention studies 
(Rich et al. 1989, Clubb et al. 1990, Lichtenstein & Chobanian 1990, Mao 
et al. 1991, Fischer Hansen et al. in press). The intervention often begins 
just after the weaning period in 6 weeks old rabbits. Despite the fact that 
the blood lipid levels in grown up WHHL rabbits have been character&d 
(Watanabe 1980, Lind et al. 1990, Esper et al. 1993a), little information on 
changes in blood lipids in growing W?XHLs during the weaning period is 
available (Rosenfeld et al. 1987~). This infotmation might improve the 
interpretation of possible changes in blood lipids in the early fase of an 
intervention study. Therefore the aim of this study was to collect infor- 
mation on physiological blood lipid levels in growing WHHL rabbits until 
3 months of age. Furthermore, since the WHKL rabbits show a reduced 
reproductive performance compared to normolipidemic rabbit strains (Shio- 
mi et al. 1987) and the information on breeding of the WHHL rabbits is 
limited, the data characterizing the reproductive performance of our colony 
and the changes in blood lipids in WHHL and New Zealand White (NZW) 
females are included in this paper. 
MATERIALS AND METHODS 
Animals. 
The homozygous and heterozygous WI-TEE rabbits used in this study 
were obtained from our own breeding colony derived from a parent gener- 
ation obtained from professor Jansen, University of Leiden, The Nether- 
lands, with permission from dr. Y. Watanabe. The young homozygous 
WHHL rabbits were derived from mating of homozygous males with 
heterozygous females, The young heterozygous WHHL rabbits were 
derived from mating of homozygous males with NZW females or 
heterozygous WHHL females. All WHHL rabbits with a total cholesterol 
higher than 10 mrnol/l at the end of weaning (6 weeks from birth) were 
considered homozygous. The young NZW rabbits were breed in our labora- 
tory from parents obtained from Thomae-Phanna-Biberach (Department of 
Laboratory Animal Service, Biberach, Germany). The microbiological 
status of ail the rabbits was conventional. 
Housing, care of animals and clinical observations. 
From six weeks of age all the rabbits were housed individually in steel 
cages under controlled environmental conditions (temperature 18 f 2’C, 
relative humidity 55 + 5%, 12/12 hrs light/dark cycle, air changed 10 
times&). All the rabbits, except for the pregnant females, were fed 100 g- 
/rabbit/day of a standard diet Altromin 2113 (Lage, Germany). From the 
mating until the end of weaning of their offsprings the females received 
feed ad lib&m and additionally 10 g oats/animal/day. All the rabbits had 
free access to tap water. The rabbits were observed at least twice a day for 
any abnormalities in the clinical condition. 
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Comparison of reproductive performance. 
Homozygous and heterozygous WHHL and NZW females were mated 
with homozygous WHHL males. The conception rate (%) was calculated 
by dividing the number of pregnant females by the number of mated 
females. The weaning rate (%) ‘was calculated for each female by dividing 
the number of weaned offspring by the litter size at birth. 
Assay of plasmu lipids. 
Blood samples were collected from the heterozygous WHHL and NZW 
breeding females before mating, 14 days after mating and 14 days after 
delivery, and from growing rabbits at 4, 6 and 11 weeks of age. All the 
rabbits except for when they were 4 weeks old were fasted from 14.00 
hours the day before blood sampling. The blood samples were collected 
from the marginal ear vein of unanesthetized animals in tubes containing 
potassium EDTA, and plasma was isolated after cennifugation at 2000g for 
10 minutes. The concennation of plasma cholesterol and plasma 
triglycerides was determined enzymatically (CHOD-PAP, GPO-PAP, 
Boehringer Mannheim and UNIMATE, Hoffman La-Roche respectively). 
Lipoproteins were separated by density gradient ultracentrifugation by the 
method of Terpstru et al. (1981). The density ranges of the isolated frac- 
tions were: very low density lipoprotein (VLDL) p<1.0063 g/ml, low 
density lipoprotein (LDL) 1.019<p<1.063, high density lipoprotein (HDL) 
1.063q. The concentration of cholesterol in each fraction was determined 
as above. 
Statistical procedures. 
The results of total plasma cholesterol, triglycerides and lipoproteins, 
data for the mean of litter sizes and weaning rates were analyzed by analy- 
sis of variance followed by Duncan’s test. The data for conception rates 
were analyzed by Fisher’s exact test. The effects were considered signifi- 
cant for p values less than 0.05. All statistical analyses were performed 
using Statistical Analysis System (SAS) software (SAS Institute Inc., 
release 6.03, 1988). 
RESULTS 
Comparison of reproductive performance. 
Table 1 shows the comparison of reproductive performance of 
homozygous and heterozygous WHHL and NZW females, all of which 
were mated with homozygous WHHL males. The conception rate of 
homozygous WHHL females was 14% lower than that of NZW and 
heterozygous WHHL females but this difference was not statistically 
significant. The litter size and the weaning rate for homozygous WHHL 
females was significantly lower than for NZW and heterozygous WHHL 
females. The litter size and weaning rate were highest in NZW females. 
However, they were not significantly higher than in heterozygous WHY-K 
females. 
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Comparison of blood lipids in heterozygous WHHL and NZW breeding 
females. 
Table 2 shows the changes in blood lipids in heterozygous WHHL and 
NZW females during gestation and lactation. No significant differences in 
total cholesterol, triglycerides and lipoproteines were recorded between the 
females from the two rabbit strains at mating, 14 days after mating and 14 
days after delivery. 
In heterozygous WHHL females the total cholesterol and LDL choles- 
terol decreased during gestation and reached the lowest value at lactation. 
At that time the values were significantly lower than at mating. In NZW 
females total cholesterol was lowest at gestation but not significantly 
different from that at mating and during lactation. In both heterozygous 
WHHL and NZW females the VLDL cholesterol was highest and HDL 
cholesterol was lowest during gestation. 
The maximum concentration of total and VLDL triglycerides was 
recorded during gestation in heterozygous WHHL and NZW females. The 
lowest LDL triglycerides were recorded during lactation in heterozygous 
WHHL females while LDL triglycerides did not change significantly in 
NZW females. The HDL triglycerides did not change significantly in 
females of any of the strains. 
Blood lipids in growing WHHL and NZW rabbits. 
Changes in the blood lipids in growing homozygous and heterozygous 
WHHL and NZW rabbits are shown in Table 3. 
In homozygous WHHL rabbits no sex difference was seen in total 
cholesterol. Age had no effect on total cholesterol apart from a transient 
lowering at 6 weeks of age for females. In triglycerides a sex difference 
was present at 11 weeks of age due to a significant decrease with age in 
females. 
In heterozygous WHHLs a sex difference in total cholesterol and 
triglycerides was present at 11 weeks of age. The total cholesterol and 
triglyceride concentrations significantly decreased with age in both sexes. 
In NZWs no sex difference was recorded in blood lipids with the 
exception of 6 weeks of age when a transient sex difference in total chole- 
sterol was observed. No sex difference was seen in the concentration of 
triglycerides. The total cholesterol and triglycerides significantly decreased 
with age in both sexes. 
Strain differences in blood lipids in growing WHHL and NZW rabbits. 
Total cholesterol was highest in homozygous WHHL rabbits and 
lowest in NZW rabbits. A significant difference between the three strains 
was recorded for females at the three ages and for males at 4 and 6 weeks 
of age. For 11 weeks old males a significant difference was recorded only 
between homozygous WHHLs and the two other strains which had com- 
parable cholesterol levels. 
Triglycerides in homozygous and heterozygous WHHL males were 
comparable and significantly higher than in NZW males at 4 and 6 weeks 
of age. At 11 weeks of age the triglycerides in homozygous WHHL males 
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were significantly higher than in heterozygous WHHL and NZW males 
which had comparable triglyceride levels. Triglycerides in homozygous and 
heterozygous WHHL females were comparable and significantly higher 
than iu NZW females at 4 weeks of age. At 6 weeks of age there was a 
significant difference in the triglyceride level between the females of the 
three smins, being highest in homozygous WHHLs and lowest in NZWs. 
At 11 weeks the triglycerides were significantly higher in homozygous 
WHHL females than in heterozygous WHHL and NZW females which had 
comparable triglyceride levels. 
DISCUSSION 
The comparison of reproductive performance of homozygous and 
heterozygous WHHL females and NZW females in our colony demon- 
strated the lowest conception rate, litter size and weaning rate in 
homozygous WHHL females while there was no difference between the 
heterozygous WHHL and NZW females. The decreased reproductive 
performance of homozygous WHHL females was the reason for prefering 
to mate heterozygous WJSLL females with homozygous WHHL males to 
obtain the homozygous offspring in our colony. 
Nor& et al. (1993) reported a higher litter size and a lower weaning 
rate for homozygous WHHL females than in our colony. Shiomi et al. 
(1987) who compared the reproductive performance of homozygous and 
heterozygous WHHL and NZW females and Japanese White females 
reported a conception rate and litter size for homozygous WHHL females 
comparable to those in our colony but a lower weaning rate. The litter size 
for heterozygous WHHL, females reported by Shiomi et al. (1987) was 
identical to ours. The conception and weaning rate for heterozygous 
WHHL and NZW females were higher in our colony than the reported by 
Shi~mi er al. (1987) for heterozygous WHHL and Japanese White females. 
Roberfs et al. (1974) reported a lower plasma cholesterol in pregnant 
and lactating normolipidemic females than in non-pregnant and non-lactat- 
ing. Kriesren & Muruwski (1981) reported for NZW females that after an 
increase of plasma cholesterol and a slight decrease in triglycerides in the 
fist week of gestation the blood lipids decreased and reached the lowest 
level at week 4 of the gestation. During the lactation the blood lipids were 
still lower than before the gestation. The observed changes in total choles- 
terol due to gestation and lactation in NZW females in our colony are in 
accordance with the reports of Roberts et al. (1974) and Kriesfen & Mu- 
ruwski (1981). The changes in total cholesterol in heterozygous WHHL 
females from our colony are also in accordance with the report of Roberts 
et al. (1993) but the lowest levels of total cholesterol were recorded during 
the lactation. In contrast to reports of Kriesten & Muruwski (1981) the 
highest levels of triglycerides in both heterozygous WHHL and NZW 
females in our colony were recorded during the gestation and the lowest 
during lactation. 
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The information on physiological levels of blood lipids in growing 
WHHL and NZW rabbits up to 3 months of age is very limited. RosenfeZd 
et al. (1987) presented a figure on temporal patterns of hypercholesterole- 
mia in homozygous WHHL and fat-fed NZW rabbits from 4 to 52 weeks 
of age. The figure demonstrated that plasma cholesterol in homozygous 
WHHLs decreased from 4, to 12 weeks of age. Lind et al. (1990) who 
investigated the age and sex related changes in blood lipids of homozygous 
WHHL rabbits from 10 to 52 weeks of age reported no sex difference in 
total cholesterol at 10 weeks of age. Furthermore, they did not report 
statistically significant difference in triglycerides, but the triglycerides 
values were slightly lower in females than in males. The results from our 
colony of WHHLs on total cholesterol and triglycerides at age the from 4 
to 11 weeks seem comparable to the report of Lind er al. (1990) for 10 
weeks old homozygous WHHLs. 
This was obvious that the homozygous WHHLs had significantly 
higher plasma cholesterol than the heterozygous WHIlLs but the interesting 
observation in this study was that the homozygous and heterozygous 
WHHLs had comparable triglycerides during weaning. A significant strain 
difference in triglyceride levels was tirst seen at 11 weeks of age when the 
rabbits were fed standard diet. 
The plasma lipids decreased with age in growing heterozygous WHHLs 
and NZWs. Some of the difference in blood lipids between 4 and 6 weeks 
of age could be ascribed to the fact that the 4 weeks old offsprings were 
not fasted before blood sampling as they stayed with their mothers while 
the 6 weeks old pups were fasted overnight as they were already housed 
individually. However, the major factor for the significant difference in 
blood lipids at the weaning and at 11 weeks of age seems to us the differ- 
ence in the amounts of ingested fats: Suckliig pups received up to approxi- 
mately 13% fat in their mother’s milk (Hugen 1974) while from 6 weeks 
of age the rabbits were offered only 3.5% fat in the standard rabbit chow. 
Lind et uZ. (1990) observed a significantly higher total cholesterol in 
WHHL females than in males first at 22 weeks of age. Roberts et al. 
(1974) reported a higher plasma cholesterol in females than in males for 
sexually matured normolipidemic rabbits. Our results for 11 weeks old 
rabbits demonstrated a higher plasma cholesterol in females than in males 
only in heterozygous WHHLs but on the other hand the 11th week of age 
may be too early for any sex differences to be established. 
CONCLUSION 
The reproductive performance of homozygous WHHL females was sig- 
nificantly decreased when compared with heterozygous WHHL and NZW 
females. In heterozygous WHHL and NZW females the plasma cholesterol 
decreased during gestation and lactation while the plasma triglycerides 
increased during gestation and were lowest during lactation when compared 
to the levels at mating. 
At the age from 4 to 11 weeks no changes were observed in 
homozygous WHHL rabbits in total cholesterol while triglycerides signifi- 
cantly decreased in females. In heterozygous WHlIL rabbits and NZW 
rabbits the blood lipids decreased significantly. Sex differences at 11 weeks 
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of age were recorded for homozygous WHHLs in triglycerides and for 
heterozygous WHHLs in total cholesterol and triglycerides while no sex 
differences in blood lipids were recorded in NZWs. The decrease with age 
in blood lipids in growing rabbits should be kept in mind when designing 
experiments beginning in animals younger than 3 months of age. 
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SUMMARY 
The aim of this study was to examine blood lipids in homozygous 
WHHL rabbits from 11 to 23 weeks of life and to compare the total cho- 
lesterol and triglycerides of adult homozygous WHHL, heterozygous 
WHHL and normolipidemic rabbits aged at least 6 months. In WHHL 
males plasma cholesterol did not change significantly from the 1 lth to 23rd 
week of age but their triglyceride level at 23 week of age was significantly 
lower (~~0.05) than at the 11th and 19th week of age. No significant 
changes with age were recorded for females apart from a transient increase 
in plasma cholesterol and triglycerides at the 19th week of age (~~0.05). 
The females had plasma cholesterol significantly higher than males at the 
15th and 19th weeks of age (p~O.05) and the triglyceride level was signifi- 
cantly lower than in males at the 11th week of age (p~O.05). No sex 
difference was seen in blood lipids of 23 weeks old and adult homozygous 
WIIHLs. The adult homozygous WHHL rabbits had significantly higher 
levels of plasma cholesterol and triglycerides compared to heterozygous 
WHHLs and NZWs due to significantly elevated LDL, VLDL and IDL 
(~~0.05). Blood lipids of adult heterozygous WHHL and normolipidemic 
rabbits were comparable. In both heterozygous and normolipidemic rabbits 
the females had a higher plasma cholesterol level than males. 
INTRODUCTION 
In 1980 Watanabe described a new rabbit strain which developed 
spontaneous atherosclerosis and exhibited heritable hyperlipidemia due to a 
recessive genetically conditioned deficiency in low density lipoprotein 
(LDL) recetitor. The homozygous Watanabe heritable hyperlipidemic 
(WIIIIL) rabbits were reported to have 8 to lo-fold increased plasma 
cholesterol and triglyceridemia compared to normolipidemic rabbits. The 
grown up heterozygous WHHL rabbits were reported to have blood lipid 
levels as normolipidemic rabbits (&per et al. 1993) or intermediate values 
between those in normolipidemic rabbits and WHHL homozygots (Gold- 
stein et al. 1983). 
In 1989 a breeding colony of WHHL rabbits was established in our 
laboratory from 2 homozygous males and 6 heterozygous females obtained 
with the permission of Dr. Y.Watanabe from professor Jansen; University 
of Leiden, Holland. Since then the WHHL rabbits from our colony have 
been used to monitor the development of spontaneous atherosclerosis in 
homozygous and heterozygous animals (IIIB.: Hansen et al. 1994) and for 
dietary and drug intervention during the first 6 months of life (IIIE., 
Mortensen et al. 1995, III.F.: Hansen et al. 1995). 
The hyperlipidemia in homozygous WHHL rabbits was reported to 
diminish with age (Watanabe 1980, Have1 et aE. 1982). Also a sex differ- 
ence in blood lipids was reported for spontaneously hyperlipidemic rabbits 
(Lind et al. 1990). The age related physiological decrease, if present, and 
possible sex difference in blood lipids might interfere with the interpreta- 
tion of the effect of drug or dietary intervention on blood lipids. It has 
earlier been demonstrated for homozygous WHHL rabbits from our colony 
that at the age from 4 to 11 weeks no significant changes in total choles- 
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terol occurred while triglycerides significantly decreased in females at the 
11th week of life (111A.I). The aim of this study was 1) to further examine 
the possible blood lipid changes from the 11th to 23rd week of life in 
homozygous WHHL rabbits i.e. up to the age of the end of the intervention 
studies, 2) to compare the concentration of plasma cholesterol and 
triglycerides in lipoproteins of homozygous WHHL, heterozygous WHHL 
and NZSV rabbits at least 6 months old and 3) to compare the physiological 
levels of total plasma cholesterol and triglycerides of adult homozygous 
WHHL, heterozygous WHHL from our colony and normolipidemic rabbits 
of different strains. 
MATERIALS AND METHODS 
Housing of the rabbits and clinical observation 
For housing conditions and clinical observation see ILE. and III.A.l. 
The rabbits were fed either lOOg/rabbit/day or ad Zibitum of a standard 
rabbit chow Altromin 2113 (Lage Germany) and had free access to tap 
water. 
Blood samples 
Repeated blood samples were collected from 36 male and 31 female 
homozygous WHHL rabbits obtained from our own breeding colony from 
11 weeks until 23 weeks of age at intervals of 4 weeks. Single blood 
samples were obtained from 4 homozygous WHHL breeding females at 
minimum 9 months old, 4 NZW breeding females (Thomae-Pharma-Bibe- 
rach, Department of Laboratory Animal Service, Biberach, Germany) at 
minimum 9 months old, 21 male and 33 female heterozygous WHHL 
rabbits 6 to 18.5 months old from our own breeding colony, 16 males and 
16 females NZW (Danish Serum Institute, Hvide Steen, Denmark) at 
minimum 6 months old, from 45 male rabbits Chinchilla (Chbb:CH) (Tho- 
mae-Pharma-Biberach, Department of Laboratory Animal Service, Biber- 
ach, Germany) approximately 6 months old and from 14 male Russian 
rabbits at minimum 6 months old (Mollegaarrl Breeding & Research Centre 
A/S, LI. Skensved, Denmark). All the rabbits were fasted overnight before 
blood sampling. Blood samples were collected from the marginal ear vein 
of unanesthetized rabbits in tubes containing potassium EDTA, and plasma 
was isolated after centrifugation at 2000g for 10 minutes. 
Assay of plasma lipids 
For description of measurement of total cholesterol see II.C.l., of total 
triglycerides see II.C.2. for measurement of total cholesterol and 
triglycerides in lipoproteins see II.C.3.. 
Statistical procedures 
The results on blood lipids were analysed as described in III.A.l.. 
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RESULTS 
Plasma cholesterol did not change significantly in homozygous WDHL 
males from 11 to 23 weeks of age but their triglyceride at 23 weeks was 
significantly lower than at 11 and 19 weeks of age. No significant age 
related changes in plasma lipids were recorded for females from 11 to 23 
weeks of age apart from a transient increase in plasma cholesterol and 
triglycerides at week 19 of age. Females had plasma cholesterol significant- 
ly higher than males at 15 and 19 weeks of age and triglycerides signiti- 
cantly lower than males at 11 weeks of age. No sex difference in blood 
lipids was recorded at 23 weeks of age (Table 1). 
The concentration of plasma cholesterol and triglycerides in 
lipoproteins of these homozygous WHHLs, 4 females and 4 males 6 
months old and 4 males and 4 females 17-18.5 months old heterozygous 
WHHLs and 6 females and 6 males NZWs are shown in Table 2. As no 
statistically significant difference in blood lipids and their concentrations in 
lipoproteins was found for heterozygous WHHL females and males of the 
two age groups their results were pooled. In homozygous WHHL rabbits 
no significant sex difference in plasma cholesterol and triglycerides in 
lipoproteins was recorded. About 50% of their total cholesterol and 44% of 
triglycerides were present in LDL. The homozygous WHHLs had signifi- 
cantly higher levels of plasma cholesterol and triglycerides compared to 
heterozygous WHHLs and NZWs due to significantly elevated levels of 
LDL, VLDL and IDL. The HDL cholesterol of homozygous females was 
significantly lower than in females from the two other strains which had 
comparable levels of this fraction. The HDL cholesterol of homozygous 
and heterozygous males was found significantly lower than in NZW males. 
The concentration of HDL triglycerides in the three normolipidemic rabbit 
strains were identical from statistical point of view. In heterozygous 
WHHL rabbits females had significantly higher total, HDL and LDL 
cholesterol compared to males. In NZW rabbits females had significanlty 
higher total and IDL cholesterol compared to males. No sex difference was 
seen in concentration of triglycerides in heterozygous WHHL and NZW 
rabbits. 
In Table 3 the results on blood lipids in adult homozygous and 
heterozygous WHHL and normolipidemic rabbits of different strains are 
compiled. The blood lipids of homozygous WHHLs were significantly 
higher than in heterozygous WHHLs and normolipidemic rabbits. The 
blood lipids of heterozygous WHHL and normolipidemic rabbits were 
comparable. In heterozygous WHHLs the females had significantly higher 
cholesterol than the males. In normolipidemic rabbits the plasma cholester- 
ol of NZW females was significantly higher than the mean plasma choles- 
terol for all males. Furtheremore, a strain difference was seen in male 
plasma cholesterol. 
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Table 3. Total cholesterol and triglycerides (mrnou1 * SD) in grown up 
homozygous and hetemzygous WHHL and nonuolipidemic rabbits. 
Rabbit sti Total cholesterol Number Triglycerides NUm- 
her 
Homozygous WHHL 
Females 26.3 f 5.1+ 35 4.00 It 1.04+ 35 
Males 24.4 f 5.26 35 4.54 f 1.816 35 
Heterozygous WHHL 
Females 1.64 f 0.66t 33 0.73 * 0.51 20 
Males 0.62 f 0.22 21 1.10 f 0.58 7 
Normolipidemic rabbits 
Females NZW 1.44 f 0.67t’ 20 0.78 i 0.26 20 
Mala Nzw 1.37 f 0.36b 16 0.99 * 0.50 16 
Males Chinchilla (ChbtKH) 1.14 f 0.32b 45 0.76 zt 0.37 45 
Males Russian 0.75 * 0.17b 14 0.35 k O.OEb 14 
Males total 1.12 * 0.36 75 0.73 f 0.42 75 
+ pcO.05 differem from hetemzygous WHHL and normolipidemic rabbits of the same sex. 
+ ~~0.05 sex difference. 
+a ~0.05 sex difference compared to total mean for males 
b pcO.05 different from values in other strains 
DISCUSSION 
Changes in plasma cholesterol in homozygous WHHL rabbits 
Previous reports have demonstrated an age dependent decrease in blood 
lipid levels in spontaneously hyperlipidemic rabbits (Watanabe 1980, Lind 
et al. 1990). However, the decrease either does not occur (Watanabe 1980, 
nora bene that the sex of animals was not stated) or is minimal in males 
(Lind et al. 1990) during the first 6 months of life. Thus, the lack of 
significant changes in plasma cholesterol of homozygous WHHL rabbits of 
both sexes from our breeding colony from 11 to 23 weeks of age is in 
accordance with the previous reports. Concerning the sex difference in 
plasma cholesterol, Lind et al. (1990) demonstrated in spontaneously 
hyperlipidemic rabbits a higher plasma cholesterol in females than in males 
from the 22nd to the 52nd week of life. In our colony, no sex difference in 
the plasma cholesterol levels was recorded in 23 weeks old and adult 
homozygous WHHL rabbits (Table 1 and 3). However, a higher female 
plasma cholesterol level was recorded at the 15th and 19th week of age. 
Thus, it may be concluded that the sex difference in plasma cholesterol 
was transcient. 
Changes in plasma triglyceridek in homozygous WHHL rabbits 
Watanabe (1980) demonstrated for homozygous WHHL rabbits that 
their plasma triglyceride values were markedly lower at 6 months of age 
than at 1 months of age. Lind et al. (1990) demonstrated a marked decrease 
in male triglyceride levels from 10 to 16 weeks of age and a lack of 
significant changes from 16 to 40 weeks of age. For female triglyceride 
levels, Lind et al. (1990) reported a slight decrease from 10 to 16 weeks of 
64 
age followed at first by an increase with the maximum value at 28 weeks 
of age and then a decrease up to 40 weeks of age. In the present study, the 
female triglycerides significantly but transiently increased at 19 weeks of 
age while the triglycerides in the males significantly decreased at 23 weeks 
when the values are compared to those at 11 and 19 weeks of age. Thus 
our findings on triglyceride changes in males are comparable to those 
reported by Wurunube (1980). 
Blood lipid levels in lipoproteins in homozygous WHHL rabbits 
The concentration of blood lipids in the lipoproteins of homozygous 
WHHl rabbits from our colony are in accordance with previous reports 
(Huvel et al. 1982, Goldstein et al. 1983). Our results confirmed that the 
hyperlipidemia is mainly associated with increased LDL levels. Further- 
more, these rabbits also have significantly increased levels of VLDL and 
IDL whereas the HDL levels are relatively reduced. 
Comparison of dutu for homozygolcs WHHL rabbits with those of 
heterozygous WHHL and normolipidemic rabbits 
The comparison of blood lipid levels in adult homozygous WHHL, 
heterozygous WHHL and normolipidemic rabbits revealed significantly 
higher plasma lipid values in homozygous WHHL animals. The values of 
plasma cholesterol were 20-fold and of triglycerides 3-to 8-fold higher than 
in heterozygous and normolipidemic rabbits. Thus the plasma cholesterol 
level in the homozygous WI-ELLS in our colony is higher than the reported 
by Watanabe (1980). Our data also showed lack of a statistically signifi- 
cant difference in blood lipids between heterozygous WHHL and normoli- 
pidemic rabbits. This is in accordance with the report of &per et al. 
(1993). The significantly higher plasma cholesterol in heterozygous WHHL 
and normolipidemic rabbit females than in males is furthermore, in accor- 
dance with the report of Roberts et al. (1974) for normolipidemic rabbits. 
In conclusion, the determinations of blood lipids in homozygous 
WHHL, rabbits from our colony from 11 weeks up to 23 weeks of age 
demonstrated only transient changes in blood lipid levels. However, these 
transient changes should be kept in mind when designing intervemion 
studies in the fist 6 months of life of homozygous WHHL rabbits. The use 
of an equal number of females and males in all experimental groups and a 
higher number of animals per ‘group is recommended as it may facilitate 
the interpretation of the effects of an intervention on blood lipid levels. 
This may prevent a possible misinterpretation of the obtained data. Further- 
more, the present study confnmed that the major carrier of plasma lipids in 
homozygous WHHL rabbits from our colony was LDL, that plasma lipids 
of adult homozygous WHHL rabbits were significantly higher than those of 
heterozygous WHHL and normolipidemic rabbits. Finally, the blood lipid 
levels of heterozygous rabbits are comparable to those in normolipidemic 
rabbits. 
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Atherosclerosis in Watanabe heritable 
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comparison of atherosclerosis variables 
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Atherosclerosis in Watanabe heritable hyperlipidaemic rabbits. Evaluation by macroscopic, micro- 
scopic and biochemical methods and comparison of atherosclerosis variables. APMIS 102: 177-190, 
1994. 
The spontaneous development of atherosclerotic disease in 38 homozygous and 34 heterozygous 
Watanabe heritable hyperlipidaemic rabbits was evaluated by qualitative and quantitative light micro- 
scopy in aorta, coronary, pulmonary and renal arteries. by naked eye and macroscopic morphometric 
estimation of aortic atherosclerosis extent and by biochemical analysis of aortic cholesterol content. 
No noteworthy atherosclerosis was demonstrated within I9 months in heterozygous rabbits. In 
homozygous rabbits, atherosclerotic lesions were seen from the age of 4 months and progressed with 
age. All 19-month-old rabbits had severe atherosclerotic disease. As much as 64% of the variation in 
atherosclerosis extent/severity could be explained by serum cholesterol and age. A highly significant 
correlation between the various methods for quantitation of atherosclerosis extent and/or severity 
was demonstrated, suggesting that quantitative mxroscopy, macroscopic morphometry and determi- 
nation of aortic cholesterol content mw be eauallv valid as a measure of atherosclerosis n WHHL 
rabbits and are therefore interchangeable. . 
Key words: Atherosclerosis; WHHL rabbits; morphology; quantitation; biochemical analysis 
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The influence of dietary olive oil and margarine on aortic 
cholesterol accumulation in cholesterol-fed rabbits maintained at 
similar plasma cholesterol level 
Alicja Mortensena, Per L. Espensenb, Birgit Fischer HansenC and Per Ibsena 
(Received 31 December, 1991) 
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The present study compares the atherogenicity of a standard diet and diets with 10% olive oil or 10% 
margarine added, in rabbits maintained at a mean plasma cholesterol level of about 20 mM for 13 weeks. 
Each group consisted of 15 animals. The distribution of cholesterol in plasma between VLDL, IDL, LDL 
and HDL was similar in the 3 groups. The thoracic aortic cholesterol accumulation was 16.6 it 1.6, 
11.4 i 1.0 (P < 0.05) and 12.6 * 1.7 (P > 0.05) nmolimg wet weight for the group receiving standard 
diet, diet with 10% olive oil added and diet with 10% margarine added, respectively. There was no signifi- 
cant difference between groups in the occurrence of the atherosclerotic changes in the proximal and distal 
parts of coronary arteries, abdominal aorta and renal arteries. The occurrence of atherosclerotic changes 
in the pulmonary arteries was equal in the groups receiving standard diet and diet with 10% margarine 
added while it was significantly lower (P < 0.05) in the group receiving diet with 10% olive oil added. The 
atherosclerotic changes at the aortic orifice of coronary arteries were quanticated morphometrically and 
were most severe in the group on the standard diet. The results indicate a comparable atherogenic effect 
of 10% olive oil or margarine addition to standard diet on development of atherosclerosis in rabbits main- 
tained at a similar plasma cholesterol level. The study also suggests that supplementation of olive oil or 
margarine to standard rabbit diet leads to lower cholesterol accumulation in the thoracic aorta compared 
with standard diet, an effect not modulated by changes in plasma cholesterol concentrations. 
Key words: Aortic cholesterol; Atherosclerosis; Olive oil; Margarine; W(NIS fatty acids; Hydrogenated fat; 
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1V.A. COMPARISON OF THE RABBIT MODELS USED IN THIS 
PROJECT AND THEIR POSITION IN ATHEROSCLEROSIS 
RESEARCH 
In the present work three rabbit models were used: the cholesterol-fed 
normolipidemic rabbit, the cholesterol-fed heterozygous WHHL rabbit and 
the homozygous WHHL rabbit. 
IV.A.l. Blood lipids and spontaneous atherosclerosis 
Physiological blood lipid levels in heterozygous WHHL rabbits are 
comparable to those of normolipidemic rabbits while homozygous WHHLs 
exhibit pronounced hyperlipidemia due to an inherited deficiency in the 
LDL receptor. The levels of plasma cholesterol and triglycerides of 
homozygous WHHL rabbits are significantly higher than in heterozygous 
WHHLs and NZWs due to significantly elevated levels of LDL, VLDL and 
IDL. During the first 6 months of life of homozygous WHHL rabbits of 
both sexes the plasma cholesterol and the triglycerides do not change 
significantly but transient fluctuation in their concentrations have been 
recorded. The blood lipids of heterozygous WHHL and NZW rabbits 
decreased significantly from the 4th to 11th week of age (ZII.A.I&2). 
In normolipidemic rabbits spontaneous aortic lesions of various 
morphologic appearance have been described (Haust & More 1965, Schenk 
et aZ. 1966) but spontaneous aortic atherosclerosis is a rare phenomenon 
(Butler & Clubb 1989). In heterozygous WHHL rabbits spontaneous at- 
herosclerosis is of little significance until the age of approximately two 
years (IIIB.: Hansen et al. 1994, Atkinson et al. 1989) but the presence of 
atherosclerotic intimal lesions of different type have been reported in 3 
years old heterozygous WHHLs (Esper et aZ. 1993). In homozygous 
WHHL rabbits spontaneous atherosclerosis develops at an early age, e.g. 
fatty streaks or fibrous plaques with occasionally foam cells were seen 
already in the aortas of 4 months old rabbits from our colony (ZIIB.: 
Hansen et al. 1994). 
IV.A.2. Position of rabbit models in atherosclerosis research 
The normolipidemic rabbit has been widely used in atherosclerosis 
research as it more readily than other laboratory species develops aortic 
lesions after cholesterol feeding, the so called experimental atherosclerosis. 
In this regard the normolipidemic rabbit has been superior to other labora- 
tory animal species used in atherosclerosis research. The homozygous 
WHHL rabbit has been applied in atherosclerosis research due to its unique 
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characteristic - the spontaneous hyperlipidemia and atherosclerosis. The 
position of heterozygous WHHL rabbit among the laboratcay animal 
models for atherosclerosis research, remains to be established. Atkinson et 
al. (1989) proposed that the heterozygous WHHL rabbit might be a more 
relevant model than its homozygous sibling since humans with heterozy- 
gous familial hypercholesterolemia ournumber those with homozygous 
familial hypercholesterolemia. Furthermore, he reported that the lesions in 
1% cholesterol-fed WHHL heterozygotes morphologically resembled those 
in WHHL homozygotes and humans. ‘This indicated the superiority of the 
heterozygous WHHL rabbit over the cholesterol-fed normolipidemic rabbit 
concerning the request of morphological resemblance between the at- 
herosclerotic lesions in the animal model and in humans. Esper et al. (1993 
a, b) suggested that the older heterozygous WHHL rabbit is superior to the 
cholesterol-fed rabbit model. This suggestion was based on the facts that in 
heterozygous WHHL rabbits 1) the age and gender dependent changes in 
blood lipids were demonstrated and 2) the atherosclerotic lesions of 3 years 
old animals were comparable to the human atherosclerotic lesions from 
morphological point of view. The studies on the heterozygous WHHL 
rabbit in our laboratory (II1.D.) demonstrated that 1% cholesterol-fed 
heterozygous WHHL rabbit was not suitable for dietary intervention studies 
due to a disturbed lipid metabolism manifested by a massive hyperchole- 
sterolemia which could mask any effect of a test compound on the blood 
lipid levels and by extravascular lipid deposition in various organs. In addi- 
tion, the atherosclerotic lesions in 1% cholesterol fed heterozygous WHHL 
rabbit were comparable to the lesions in the normolipidemic cholesterol-fed 
rabbits receiving lower cholesterol doses and in 6 months old homozygous 
WHHL rabbits. The latter observation suggests that the normolipidemic 
rabbit fed low cholesterol doses like in IILC. {Mortensen et al. 1992) may 
be a better model than 1% cholesterol-fed heterozygous WHHL rabbit. 
This is due to the fact that it develops atherosclerotic lesions of similar 
morphology without extreme hypercholesterolemia which can affect the 
outcome of any study. However, a comparison of atherosclerotic lesions in 
heterozygous WHHL and normolipidemic rabbits fed identical cholesterol 
doses at levels lower than 1% was not conducted in the present project. 
Therefore, it cannot be excluded that the atherosclerotic lesions due to 
lower cholesterol doses in heterozygous WHHLs would be of closer resem- 
blance to atherosclerotic lesions in homozygous WHHLs than those in 
normolipidemic rabbits fed identical cholesterol doses. The suggestion of 
Esper et al. (1993 a, b) of using older heterozygous WHIIL rabbit as a 
model in atherosclerosis research does not seem advantageous from a 
practical point of view. The price of a 2-3 years old rabbit is higher than of 
a rabbit which is not less than 6 months old due to the maintenance cost. 
The purchase of a sufficient number of 2-3 years old animals may be 
difficult or at least time demanding. Furthermore, the use of animals with 
already existing spontaneous atherosclerotic lesions demands more animals 
per experimental group to ensure the detection of any differences in the 
aortic and/or coronary atherosclerosis due to the intervention. The dietary 
or medicamental prevention studies in this model may provide false results 
because lesions already existing probably cannot be prevented. If 
heterozygous WHHL was chosen for studies of prevention of spontaneous 
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atherosclerosis the younger subjects without detectable atherosclerotic 
lesions should probably be used and the larger than traditionally experi- 
mental groups should probably be employed in order to ensure the correct 
interpretation of the results. Furthermore, the intervention should end 
approximately at the time when 100% of the nontreated animals was 
expected to have developed spontaneous changes. However, this would 
mean an increase use of animals and an experimental period of about 2-3 
years. On the other hand the heterozygous WHHL rabbit/cholesterol-fed 
heterozygous WHHL rabbit could be expected to be more sensitive than 
normolipidemic rabbit/cholesterol-fed normolipidemic rabbit to atherogenic 
effect of different environmental factors due to its heterozygous genetic 
background for spontaneous atherosclerosis. However, no reports on this 
subject are, to the author’s knowledge available at present. 
The position of the cholesterol-fed rabbit based on normolipidemic 
strains in atherosclerosis research is well established in spite of some 
differences in physiological lipid metabolism between the normolipidemic 
rabbit and human and in spite of the different origin of hypercholestero- 
lemia in cholesterol-fed rabbit and man (I.D.). Because of these differences, 
the atherosclerosis in cholesterol-fed rabbit should always be regarded as a 
model of human disease and never as an analogous disease process. The 
normolipidemic rabbit is very sensitive to dietary cholesterol. Like humans 
can be classified as hypo- or hyper-responders with regard to the choles- 
terolemic response to dietary modifications, the rabbits are classified as 
hypo- or hyper-responders to dietary cholesterol. Even if strains of rabbit 
hypo- and hyper-responders have been developed in some laboratories 
(Loose-Mitchell et al. 1991, Overt& & Loose-Mitchell 1992, Thiery et al. 
1995), the dietary or medicamental intervention or screening of lipid 
lowering compounds is routinely performed in groups comprising both 
kinds of cholesterolemic responders. This is the reason for occasional large 
interindividual variations in the plasma cholesterol and in the severity and 
extent of aortic atherosclerosis in the same treatment group despite the fact 
that all the rabbits are treated with the same cholesterol dose. Even a 
controlled individual cholesterol dose regimen which diminishes the differ- 
ences in plasma cholesterol does not reduce the interindividual variation in 
severity and extent of aortic atherosclerosis (Fig. 7, p. 134). The interindi~ 
vidual variation in response to cholesterol feeding should be kept in mind 
when taking a decision on the necessary number of animals per experi- 
mental group. The cholesterol dose or the level of a plasma cholesterol 
maintained at certain concentration during the study are of crucial import- 
ance in experiments in cholesterol-fed rabbits as a too severe or too low 
experimental hypercholesterolemia may mask the effects of intervention on 
plasma lipids and aortic atherosclerosis in this model. Also the duration of 
the exposure to exogenous cholesterol should be carefully chosen as a too 
short or too long exposure may. affect the outcome of the study. In contrast 
to the mentioned factors, the age of animals at the start of the study is a 
secondary issue because of a very limited occurrence of any spontaneous 
atherosclerotic lesions. 
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Fig.7. Individual cholesterol accumulation in inner proximal layer of thoracic aorta 
of the rabbits from IILC. fed standard diet added cholesterol (“fat free”), standard 
diet added cholesterol and 10% olive oil, standard diet added cholesterol and 10% 
PAN-margarine and maintained on mean plasma cholesterol of 20.1,22.5 and 20.5 
mmoUl respectively due to controled individual cholesterol dose regimen. - 
marks the mean level of accumulated cholesterol in each group. 
The homozygous WHHL rabbit has a well established position in 
atherosclerosis research as an animal model of human FH because several 
similarities between the disease process in these rabbits and in humans 
have been established (I.D.4.). The disease in the homozygous WHHL 
rabbit can be regarded as analogous to this particular human disease. 
Therefore this animal model seems excellent for development and testing 
of causal treatment e.g. gene therapies of PH. Additionally, the results of 
conventional symptomatic intervention (e.g new lipid lowering compounds) 
or other nongenetic intervention (e.g. modulation of dietary factors) in this 
model seem to be directly relevant for patients with FH. Furthermore, these 
results may be of importance for the prevention and treatment of 
atherosclerosis in patients who have two functional LDL receptor genes but 
who suffer from other forms of endogenous hypercholesterolemia which is 
aggravated by exogenous factors such as a high intake of fat, cholesterol or 
calories. In this regard the homozygous WHHL rabbit is not a better model 
than the cholesterol-fed rabbit as the etiology of disease in both animal 
models is different than in this category of human patients who develop 
atherosclerosis. It has been suggested that treatment directed at counter- 
acting high LDL levels has beneficial effects in reducing atherosclerosis 
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while treatment directed toward the modification of conventional risk 
factors (e.g. reducing plasma cholesterol and platelet adhesion) or delaying 
certain mediators of tissue injury does not prevent or reduce atherosclerosis 
in homozygous WHHL rabbits (Buja et ai. 1990). This suggestion means 
an important handicap for the model and a limitation of its use in 
atherosclerosis research. However, the results of two intervention studies in 
homozygous WHHL rabbits included in this project demonstrate the oppo- 
site. The calcium-channel antagonist -(-)anipamil delayed the development 
of atherosclerosis in homozygous WHHL rabbits (IBF.). Also the treat- 
ment with fish oil with a high content of n-3 polyunsaturated fatty acids 
decreased the blood lipid levels and the development of aortic 
atherosclerosis compared to olive oil treatment (lI1.E.). It seems that in the 
homozygous WHHL rabbit model the age of animals at the start of the 
intervention is crucial for detection of its positive or negative effects as the 
atherosclerotic changes once started cannot be prevented but may be 
delayed. The degree of aortic atherosclerosis in this model depends on the 
total cholesterol and age (ELB.). Therefore the intervention should begin 
before the atherosclerotic lesions are detectable by light microscopy. Fur- 
thermore, the homozygous WHKL rabbit might not be suitable for studies 
on regression of atherosclerosis after withdrawal of an exogenous athero- 
genie factor, because the effect of the withdrawal may be masked by the 
effect of endogenous atherogenic factor, the genetic defect, which is always 
present in the animal. This however should be verified by further investiga- 
tions. Other important issues which should be kept in mind while designing 
the studies in homozygous WHHL rabbits are the decrease with age in 
blood lipids in older animals observed in other laboratories (Watmabe 
1980, Lind et al. 1990) and a possible occurrence of transient fluctuations 
in blood lipid levels up to 6 months of life (IlI.A.18~2) as well as the inter- 
individual variation in plasma cholesterol and the degree of sonic 
atherosclerosis (BLB.). 
IV.A.3. Comparison of cholesterol-fed and homozygous WHHL rabbit 
models 
The comparison of the cholesterol-fed and homozygous WHHL rabbit 
models (Table, p. 136) emphasizes the major difference between them - the 
nature of atherosclerosis. However, the morphologic and biochemical 
studies on the development of atherosclerosis from other laboratories 
indicate that key processes involved in lesion initiation and progression are 
the same in both models in spite of the different origin of hypercholestero- 
lemia (Rosenfeld et al. 1987 a,. b). As presented in the Table, both models 
have specific characteristics which point to some specific rules for the 
application of the models and for the study design. For instance, homozy- 
135 
Table: Similarities and differences’ between the cholesterol-fed and 
homozygous WHHL rabbit models. 
Cholesterol-fed rabbit Hotnozygous WHHL rabbit 
Hypercholesterolemia and 
atherosclerosis due to exogenous 
cholesterol = experimental 
atherosclerosis. 
Hypercholesterolemia and 
atherosclerosis due to genetic defect 
= spontaneous disease. 
l.nterindividual variation in hyper- 
cholwerolemic response to exw 
genoos (dietary) cholesterol. 
- Interindividual variation in plasma 
cholesterol. 
Interindividual variation in degree 
of experimental atherosclerosis. 
- Interindividual variation in degree 
of spontaneous athemsclemsis. 
Major carrier of plasma cholesterol - Major carrier of plasma cholesterol 
is p-VLDL. is LDL 
The earliest detectable vents in ex- - 
perimental atherosclerosis are 
increased monocyte adherence and 
their subendothelial migration fol- 
lowed by formation of fatty streaks 
composed primarily of 
macrophage-derived foam cells. 
The earliest detectable vents in 
spontaneous atherosclerosis are 
increased monocyte adherence and 
their subendothelial migration fol- 
lowed by formation of fatty streaks 
composed primarily of macrophage- 
derived foam cells. 
Morphology of atherosclerotic 
lesions due to high cholesterol 
doses is different from that in 
humans. However, lower choles- 
terol doses can result in changes 
which may resemble human 
atherosclerotic lesions. 
- Morphology of advanced 
atherosclerotic lesions is considered 
a close resemblance of human 
atherosclerotic lesions. 
Experimental disease progresses 
only as long as the animal is 
exposed to the exogenous choles- 
terol. 
- Spontaneous disease progresses with 
age. 
Atherogenic factor can be retracted. - 
Age of animals at the start of the - 
experiment is of little importance. 
Instead, the level of cholesterol 
dose or level of aimed plasma 
cholesteml concentration during the 
study are of crucial importance for 
the sensitivity of the animal model. 
Atherogenic factor always present. 
Age of animals at the start of expb 
rirnent is of crucial importance for 
the sensitivity of the animal model. 
Too short or too long exposure to 
exogenous cholesterol may give 
rise to a false result of the study. 
- Too short or too long duration of 
the study may give rise to a false 
result. The factor which seems 
important for determination of the 
duration of the study is the optimal 
animal age with regard to differen- 
tiation of atherosclerotic lesions 
between tumeated control and 
ueak?d groups. 
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gous WHHL rabbits should enter the intervention study just after the 
weaning, before the spontaneous atherosclerotic lesions are established. The 
cholesterol-fed rabbit model offers posibility to use older animals at the 
start of cholesterol feeding without risking that spontaneous atherosclerosis 
would interfere with the interpretation of the experimental results. The dis- 
tinctive features of both models suggest they are not merely substitutes for 
each other but two different models based on the same animal species 
which may supplement each other. Examples of published contradictory 
results on the effect of the calcium antagonist verapamil, the compound 
probucol or L-arginine on experimental atherosclerosis in cholesterol-fed 
NZW rabbits or spontaneous atherosclerosis in WHHL rabbits (Tilton et al. 
1985, Buja et al. 1990, Cooke et al; 1992, Mortensen et al. 1995) could 
support this suggestion. However, an additional reason for the divergence 
in the results in the two models could be that some of the rules concerning 
study design due to the distinctive features of the models (e.g. too high 
hypercholesterolemia in cholesterol-fed rabbit, age at the start of the study 
in homozygous WHHL rabbits) were unintentionally disregarded while 
designing some of the studies mentioned above. This leads to another 
important issue, which should be emphasized, and which concerns the 
homozygous WHHL rabbit. The mean plasma cholesterol level may vary 
between the different breeding colonies depending on the range of plasma 
cholesterol level that has been maintained in breeding animals and on the 
fat content and composition of breeding diet used in the colony. Keeping in 
mind that the degree of aortic atherosclerosis in this model depends on the 
level of total cholesterol and age @LB.) one could expect that the fit 
detectable atherosclerotic changes may occur at different age in rabbits 
from different breeding colonies. This means that the optimal age for the 
start and termination of the study may be different for homozygous WHHL 
rabbits from separate breeding colonies. Therefore a detailed knowledge of 
development and progress of spontaneous atherosclerosis iu the line of 
homozygous WHHL rabbit applied for the study is essential for the effi- 
cient experimental design. Furthermore, the data from ,historical controls 
from the same line of homozygous WHHL rabbits and kept under compa- 
rable conditions may contribute to the interpretation of experimental data. 
Thus the possibility of keeping own breeding colony with well charac- 
terized atherosclerosis parameters is of a great advantage even now when 
the homozygous WHHL rabbit. has become commercially available. Addi- 
tionally, home-breeding permits to chose animals with comparable plasma 
cholesterol levels for a study which means a reduction of interindividual 
variation of this parameter. 
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1V.B. CONCLUSION 
In the present work, the 1% cholesterol-fed heterozygous WHHL rabbit 
was found not suitable for dietary intervention studies due to a disturbed 
lipid metabolism manifested by a massive hypercholesterolemia which 
could mask any effect of a test compound on the blood lipid levels and by 
extravascular lipid deposition in various organs. The cholesterol-fed normo- 
lipidemic and homozygous WHHL rabbits seem both useful and equally 
important animal models in atherosclerosis research except for a particular 
application like testing of specific therapies for FH for which the 
homozygous WHHL is unquestionably the model of choice. When the 
human atherosclerosis due to hypercholesterolemias caused by other factors 
than in FH is concerned, both models can be used but the differences in 
etiology between the disease in the laboratory animal models and in 
humans should be considered. The cholesterol-fed and the homozygous 
WHHL rabbits have their specific characteristics which determine the 
principles for the study design and the domain of their application. Thexe- 
fore the two models should be regarded as supportive for each other, rather 
than interchangeable. Although key processes in the initiation and pro- 
gression of atherosclerotic lesions are similar in the cholesterol-fed and 
homozygous WHHL rabbits the hypercholesterolemia is of different origin. 
Therefore the testing of new therapies, new compounds or dietary modifi- 
cations in both models, instead of only one, may provide more information 
on the mechanism of their antiatherogenic or atherogenic action. 
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SUMMARY 
Laboratory animal models play an important role in atherosclerosis 
research (chapter I.C.l.-3.). One of the most popular laboratory animal 
species in this field of research is the rabbit (chapter I.C.4.). The rabbit 
fulfils most of the criteria for an animal model for human atherosclerosis 
(chapter I.D.l). In this project the following rabbit models were estab- 
lished, used to compare the atherogenic effect of chosen dietary fats, and 
evaluated: 1) the cholesterol-fed normolipidemic rabbit, 2) the 1% choleste- 
rol-fed heterozygous Watanabe heritable hyperlipidemic (WHHL) rabbit 
and 3) the homozygous WHHI+ rabbit ( chapter I.D.3.). The reproductive 
performance in homozygous WHHL females was significantly decreased 
when compared to heterozygous WHHL or New Zealand (NZW) females 
(chapter III.A.l.). Physiological blood lipid levels in the heterozygous 
WHHL and in the normolipidemic rabbits were comparable. The blood 
lipid levels in homozygous WHHL rabbits were significantly higher than in 
heterozygous WHHL and normolipidemic NZW rabbits due to significantly 
elevated levels of low density lipoproteins (LDL), very low density 
lipoproteins (VLDL) and intermediate density lipoproteins (IDL). During 
the tirst months of life of homozygous WHHL rabbits of both sexes the 
plasma cholesterol and triglycerides did not change signiticantly but transi- 
ent fluctuations in their concentrations were recorded. The blood lipids of 
heterozygous WHHL and NZW rabbits decreased significantly from the 4th 
to the 11th week of age (chapter III.A.l & 2.). In homozygous WHHL 
rabbit spontaneous atherosclerosis develops at an early age, e.g. the 
atherosclerotic lesions detectable by light microscopy were demonstrated 
already in the aorta of some 4 months old rabbits. No noteworthy 
atherosclerosis was demonshated within the first 19 months in heterozy- 
gous WHHL rabbits (chapter IILB.). The atherosclerotic lesions in choles- 
terol-fed normolipidemic rabbits maintained at a plasma cholesterol level of 
approximately 20 mmol/l during 93 days were composed of loosely tex- 
tured connective tissue with varying amounts of lipid-laden macrophages. 
The atherogenic effect of margarine (hydrogenated fat) and olive oil was 
comparable in this rabbit model (chapter IILC.). The atherosclerotic lesions 
in 1% cholesterol-fed hetemzygous WHHL rabbits were fibrous plaques 
(i.e. discrete fibrous thickenings) and fibrous plaques with a few foam 
cells. The morphology of these lesions was similar to lesions in cholester- 
ol-fed normolipidemic rabbits from the study 1lI.C. and to lesions in 6 
months old homozygous WHHL rabbits from IILB. The study demon- 
strated that the 1% cholesterol fed rabbit was not a suitable model for 
dietary studies due to a disturbed lipid metabolism manifested as a massive 
hypercholesterolemia which could mask any effect of a test compound on 
the blood lipid levels and by extravascular lipid deposition in various 
organs. Irrespective the limitation in the use of this model it was shown 
that the marine oil seemed to protect against the development of 
atherosclerosis in the pulmonary srteries and prevented lipid accumulation 
in the myocardium, but was associated with a severe lipid infiltration in the 
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liver, and was more atherogenic than the vegetable oil based on the mor- 
phological appearance of the aortic and coronary atherosclerosis (chapter 
BID.). The comparison of olive oil and fish oil effect on blood lipids and 
spontaneous atherosclerosis in homozygous WHHL rabbits indicated a 
hypolipidemic effect and lower atherogenicity of fish oil, as lower plasma 
lipids and a lesser degree of aortic atherosclerosis were recorded in the fish 
oil treated animals when compared to olive oil treated animals (chapter 
IKE.). The calcium antagonist (-)-anipamiI delayed the development of 
atherosclerosis in homozygous WHHL rabbits when compared to untreated 
controls (chapter IILF.). The position of the heterozygous WHHL rabbit 
among the laboratory animal models for atherosclerosis research remains to 
be clarified. The position of the cholesterol-fed normolipidemic rabbit and 
the homozygous WHHL rabbit is well established in atherosclerosis 
research (chapter IV.A.2). Both models have their specific characteristics 
which determine the domain of their application and suggest that they 
should be regarded as supportive for each other, rather than interchange- 
able. Although key processes in the initiation and progression of 
atherosclerotic lesions are similar in the cholesterol-fed and homozygous 
WHHL rabbits the hypercholesterolemia is of different origin (chapter 
IV.A.3). Therefore testing of new therapies, new compounds or dietary 
modifications in both models, instead of only one, may provide more infor- 
mation on the mechanism of their antiatherogenic or atherogenic action 
(chapter IV.B.). 
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SAMMENDRAG 
Dyremodeller baseret pfi laboratoriedyr spiller en vigtig rolle i athe- 
roskleroseforskningen (kapitel I.C.l.-3.). En af de mest anvendte dyrearter 
pa dette forskningsomrade er kaninen (kapitel I.C.4.). Kaninen opfylder de 
fleste krav, som stllles til en dyremodel for human atherosklerose (kapitel 
I.D.1). I dette projekt blev felgende kaninmodeller etableret, anvendt til at 
sammenligne den atherogene effekt af udva.lgte fedtstoffer, og evalueret: 1) 
Den kolesterolfodrede normolipidaemisk kanin, 2) den heterozygote Wata- 
nabe Heritable Hyperlipidemic (WHHL) kanin fodret 1% kolesterol, og 3) 
den homozygote WHHL kanin (kapitel III.D.3.). Reproduktionsevnen hos 
homozygote WHHL hunkaniner var signifdmnt nedsat sammenlignet med 
reproduktionsevnen hos heterozygote WHHL hunkauiner eller New Zealand 
White (NZW) hunkaniner (kapitel III.A.1.). Det fysiologiske niveau af 
blodlipider hos heterozygote WHHL og nonnolipidiemiske kaniner var 
sammenligneligt. Det fysiologiske niveau af blodlipider hos homozygote 
WHHL kaniner var signifiit hojere end hos heterozygote WHHL og 
normolipidremiske NZW kaniner pii grund af et signifikant forhojede 
niveauer af low density lipiproteiner (LDL), very low density lipoproteiner 
(VLDL), og intermediate density lipoproteiner (IDL). Koncentrationen af 
plasmakolesterol og plasmatriglycerid sendrede sig ikke signiftiant i de 
forste 1evemSneder hos homozygote WHHL kaniner af begge ken, men 
forbigaende rendringer af koncenrrationen blev obsetveret. Hos heterozygo- 
te WHHL kaniner og NZW kaniner blev en signifiiaut nedgaug i kon- 
centrationen af blodlipider observeret fra 4. til 11. leveuge (kapitler III.A.l. 
& 2.). Den spontane atherosklerose hos homozygote WHHL kaniner ud- 
vikles i en tidlig alder. F.eks. blev lysmikroskopiske atherosklerotiske 
forandringer allerede observeret hos nogle 4 m&neder gamle dyr. HOS 
heterozygote WHHL kaniner blev ingen bemaxkelsesvaxdige spontane 
atherosklerotiske forandringer observeret i de forste 19 levemiineder (kapi- 
tel 1II.B.). De atherosklerotiske. forandringer hos kolesterolfodrede, normo- 
lipidsemiske kaniner med en fast plasma kolesterolkoncentration pa 20 
mmol/l i l&et af 93 dage, bestod af fibrese plaques med fa skumcelIer. 
Den atherogene effekt af margarine (hydrogeneret fedt) og olivenolie var 
sammenlignelig i denne kaninmodel (kapitel BLC.). De atherosklemtiske 
forandringer hos heterozygote W&II-IL kaniner givet foder med 1% kole- 
sterol var fibrese plaques uden eller med fa skumceller. Disse forandringer 
lignede forandringeme hos de kolesterolfodrede normolipidaemiske kaniner 
fra undersogelsen i kapitel IILC. og forandtinger hos 6 m&ueder gamle 
homozygote WHHL kaniner fra undersegelsen i kapitel IILB.. Resultater 
fra forseget i kapitel lI1.D. viste, at den heterozygote WHHL kanin givet 
foder med 1% kolesterol ikke var en veleguet model til at undersoge 
kostens effekt pa eksperimentel atherosklerose pa grund af et forstyrret 
fedtstofskifte. Dette s&s som en svaer grad af hyperkolesterolmmi og eks- 
travaskulsere fedtaflejriuger i diverse orgauer. Den sviere hyperkolesterolm- 
mi kan tilslore alle effekter af teststofferne pa koncentrationen af blod- 
lipider. Uanset begrsensningeme af denne model har undersogelsen vist, at 
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den anvendte marine olie tilsyneladende beskyttede mod udvikliugen af 
atherosklerose i lungearterierne og forhindrede aflejrlng af fedt i myocardi- 
et, men var associeret med sxere fedtinfiitrationer i leveren. Marine olie 
var mere atherogen end den vegetabilske olie vurderet ud tia den morfo- 
logiske billede af atherosklerose i aortaen og koronararteiieme (kapitel 
BID.). En sammenligning af effekten af fiskeolie og olivenolie pa spontan 
atherosklerose hos homozygote WHHL kaniner viste en hypolipid=misk 
effekt og mindre udtalt atherogen effekt af tiskeolien, idet der s&s et lavere 
niveau af blodlipider og en mindre grad sf atherosklerose i aorta hos 
dyrene behandlet med fiskeolie (kapitel IKE.). Kalciumantagonisten (-)- 
anipamil forsinkede udviklingen af atherosklerose hos homozygote WHHL 
kaniner sammenlignet med en ubehandlet kontrolgruppe (kapitel IKF.). 
Anvendeligheden af den heterozygote WJIHL kauin i forhold til a&e 
dyremodeller i atheroskleroseforskniigen skal afklares. Den kolesterolfod- 
rede notmolipi~ske kanin og den homozygote WHHL kanin er aner- 
kendte dyremodeller i atheroskleroseforskningen (kapitel IV.A.2.). Begge 
modeller har deres specitlkke egenskaber, som bestemmer detes anvendel- 
sesmuligheder, og som antyder, at de best supplerer og ikke erstatter hinan- 
den. Skont negleprocesseme i iiiitieringen og udviklingen af atheroskleroti- 
ske laesioner er sammenlignelige i den kolesterolfodrede kanin og den 
homozygote WHHL kanin er hyperkolesterohemien af forskellig oprindelse 
(kapitel IV.A.3.). Derfor kan afprWning af nye terapier, nye stoffer eller 
kostaendringer i begge modeller i stedet for kun i en af disse bidrage med 
flere oplysninger om deres antiatherogene eller atherogene virkninger 
(kapitel lV.B.). 
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LIST OF ABBREVIATIONS 
(All the abbreviations are also explained in the text where they are intro- 
duced.) 
AI 
ApoB-100 
BHT 
bw 
CETP 
CHD 
EDTA 
FCH 
FH 
HDL 
HP 
IDL 
IEL 
LCAT 
LDL 
LDLR 
LPL 
meq 
MUFA 
NZW rabbit 
PBS 
PUFA 
Ratio I/M 
SFA 
SR 
VLDL 
WHHL rabbit 
Area of intima 
Apolipoprotein B-100 
Butylated hydroxytoluene 
Body weight 
Cholestryl ester transfer protein 
Coronary heart disease 
Ethylenediaminetetra acetic acid disodium salt 
Familial combined hyperlipidemia 
Familial hypercholesterolemia 
High density lipoprotein 
Hepatic lipase 
Intermediate density lipoprotein 
Internal elastic lamella 
Lecithin cholesteryl acyluansferase 
Low density lipoprotein 
Low density lipoprotein receptor 
Lipoprotein lipase 
Miiequivalent 
Monounsaturated fatty acid(s) 
New Zealand White rabbit 
Phosphate buffered saline 
Polyunsaturated fatty acid(s) 
Ratio intima/media 
Saturated fatty acid(s) 
Scavenger receptors 
Very low density lipoprotein 
Watauabe heritable hyperlipidemic rabbit 
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